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 The coelomic hemoglobin, dehaloperoxidase (DHP), from the sea worm 
Amphitrite ornata, is a dual function oxygen-binding heme protein that also possesses a 
significant peroxidase activity. As evolved from an ancient oxygen carrier globin, several 
structural adaptations have enabled DHP to evolutionally gain significantly enhanced 
peroxidase capability for self-protection while only minimally compromising its primary 
function as an O2 carrier. To elucidate these adaptations, the peroxidase activities and O2 
affinities of several DHP and sperm whale myoglobin (Mb) mutants have been prepared. 
Several heme environmental structural factors that regulate the dual functions of DHP 
have been found, providing insight into how DHP has gained significantly enhanced 
enzymatic capability in an evolutional process for protection from its toxic living 
environment without compromising its primary function as an O2 carrier. As to the 
question how DHP interconverts the different oxidation states of heme required for its 
hemoglobin (FeII) and peroxidase (FeIII) functions, a functional switching mechanism of 
DHP has been proposed and carefully tested. Using stopped-flow methodology, the 
H2O2-mediated conversion of oxy-Fe(II) DHP to the ferric state triggered by both 
biologically relevant (TCP etc.) and non-relevant (ferrocyanide, etc.) compounds was 
examined. It has been found that ferric heme ligands and spin-trapping reagents can 
completely inhibit the TCP-triggered DHP functional switch, strongly supporting a 
proposed mechanism involving substrate radicals (TCP⋅). 
vii!
        To thoroughly study the structures and the functions of the diverse heme enzymes, 
numerous heme iron model systems have been developed. Using the H93G Mb cavity 
mutant, pioneered by Barrick, our laboratory has successfully prepared several model 
heme complexes of defined structure. However, previous attempts to generate H93G 
adducts with spectral properties resembling those of ferrous thiolate-ligated heme 
proteins such as cytochrome P450 (P450) and C. fumago chloroperoxidase (CPO), were 
not successful. In the second part of the dissertation, the first H93G Mb spectral models 
for ferrous P450 and CPO have been generated with phosphine as the axial ligand. The 
novel heme-phosphine complexes have been comprehensively characterized in their 
ferric, ferrous and ferryl states with UV-visible absorption and MCD spectroscopy. The 
data provide important insight into the unique spectral properties of thiolate-ligated heme 
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Introduction to Part I: 










 Heme Proteins 
        About one quarter to one third of all proteins require metals to carry out their 
functions [1]. Such proteins are generally termed as “metalloproteins”. Among them, the 
heme-containing proteins are an important class that carries out a diverse range of 
biological functions. One old and universal function of heme protein is the storage and 
transport of oxygen molecule carried out by hemoglobin (Hb)/myoglobin (Mb), the blood 
pigment. Some heme proteins are enzymes that catalyze the biological redox reactions 
such as cytochromes P450s. Other heme proteins play essential roles in electron transfer 
(e.g. cytochrome b5 and c) and signal transduction (e.g. CooA). 
        Most native heme proteins contain an iron-protoporphyrin IX group (heme b) with 
the iron atom coordinated in the center by four pyrrole nitrogens and two vacant 
coordination positions available for additional ligands (Figure 1.1). In heme proteins, the 
heme prosthetic group is tethered to the protein backbone via a proximal amino acid 
ligand that covalently binds to the heme iron. The functions of heme proteins depend 
largely on the properties of the heme active site which is strongly influenced by three 
factors: the iron oxidation and spin states, the nature of axial ligands coordinated to the 
iron and the surrounding protein environment which affects the binding of the substrates.  
 
Peroxidases 
        The heme enzymes that catalyze oxidation of organic substrates can be generally 
dividend into two classes: oxygenases and peroxidases. The former uses O2 to oxidize 
substrates (Eq. 1.1, showing reaction catalyzed by monooxygenase) and the latter uses 




Figure 1.1. The structure of protoheme IX (iron protoporphyrin IX, heme b). The Greek 
letters α to δ identify the sites of four each methane bridges and the Roman letters A to D 
indicate the location of four pyrrole rings. An IUPAC numbering system is used here and 
thus the carbons at 2, 3, 7, 8, 12, 13, 17 and 18 positions correspond to those at 1, 2, 3, 4, 








        AH + O2 + 2H+ + 2e-  !  AOH +H2O (1.1) 
AH2 + H2O2  !  A + 2H2O (1.2) 
Figure 1.2 elucidates the mechanism of action for peroxidases in comparison with 
oxygenases. For peroxidases like horseradish peroxidase (HRP), the addition of H2O2 to 
the ferric heme yields an unstable hydroperoxide adduct (commonly known as compound 
0). Followed by heterolysis of the O-O bond, a high-valent oxidant intermediate called 
compound I (Cpd I) is formed. Cpd I is an O=FeIV cation radical with an odd electron 
located on the porphyrin (porphyrin π cation radical). In some peroxidases, the Cpd I 
transforms to an equivalent oxidant traditionally called Cpd ES with the odd electron 
relocated to a nearby Trp or Tyr. The CpdI/CpdES oxidizes the organic substrate and 
returns to ferric state, which is a process consisting of two sequential one-electron steps 
for peroxidases involving another ferryl intermediate named Cpd II (O=FeIV) (not 
shown). The organic substrates were oxidized to radicals (AH•) that either 
disproportionate (Eq. 1.3) or dimerize (Eq. 1.4). By comparison, oxygenases like 
cytochrome P450 follow a more complicated catalytic mechanism involving an electron 
transfer system to generate Cpd I, which is again the active enzyme oxidant.   
AH• + AH•  !  AH2 + A  (1.3) 
AH• + AH•  !  HA-AH  (1.4) 
        Typical peroxidases contains a single polypeptide of 30~50 kDa and a heme b 
prosthetic group. Based on the sequence homologies and crystal structures, peroxidases 
are generally divided into two classes: mammalian and nonmammalian types. Examples 





Figure 1.2. Activation of O2 and H2O2 by monooxygenase and peroxidase, respectively, 



































lactoperoxidase (LPO) in milk and thyroid peroxidase. The non-mamalian peroxidases 
have been found in yeast (e.g. cytochrome c peroxidase), fungi (e.g. lignin peroxidase) as 
well as plants (e.g. horseradish peroxidase). At present, over 700 peroxidase structures 
are available in the Protein Data Bank (PDB). The overall foldings and active site 
structures are well conserved (except for the two recently discovered globin peroxidases 
Amphitrite ornata dehaloperoxidase and Notomastus lobatus chloroperoidase).  
        The crystal structure of the yeast cytochrome c peroxidase (CCP) was the first heme 
peroxidase to be solved by X-ray crystallography (Figure 1.3) [3]. A close-up 
examination (Figure 1.3, right panel) reveals a charge relay network involving the 
proximal Asp/His and the distal His/Arg groups. Poulos and Kraut proposed a “push-
pull” mechanism for the formation of peroxidase Cpd I, which is the most crucial step in 
the peroxidase catalytic path [4].  As shown in Figure 1.4, the proximal ligand His175 
forms a hydrogen bond with the nearby Asp235 carboxylate group, which gives the 
proximal His partially deprotonated histidinate character. This provides an electron 
“push” to the heme iron. On the distal side, the cationic Arg48 provides a “pull” effect by 
dispersing the developing negative charge on the outer O atom of the bound H2O2. The 
adjacent His52 also contributes as a general acid/base catalyst, deprotonating the inner O 
and transferring the proton to the outer O. The “push” and “pull” machinery works 
together to heterolytically cleave the O-O bond in heme-bound H2O2, resulting in 
formation of Cpd I with release of a water molecule.  
 
Globins 





Figure 1.3. X-ray crystal structure of yeast CCP with the active site enlarged on the right 














Figure 1.4. “Push-Pull” paradigm for heterolytic O-O bond cleavage in peroxidases 















Figure 1.7. “Push-Pull” paradigm for heterolytic O-O bond cleavage in His-ligated 
peroxidases [adapted from reference (13)]. 
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a globin consists of several alpha helixes that form an overall globular shape and a heme 
cofactor whose center iron is where the O2 binds. Myoglobins (Mb) are found in muscle 
cells and serve as an O2 reservoir. Hemoglobins (Hb) circulate throughout the organisms, 
delivering O2 to tissues for respiration. The first X-ray structure of globin was solved in 
1958 by John Kendrew for sperm whale Mb [6]. It is a monomer consisting of 154 amino 
acids. Hb typically contains multiple subunits that may bind O2 cooperatively, i.e. the O2 
affinity increases along with the saturation of O2 due to the conformational changes upon 
ligand-binding and the dynamic correlations between subunits.         
        The globin function, i.e. reversible O2 binding, is regulated by several factors such 
as heme iron oxidation state, reduction potential and the amino acids surrounding heme 
[7-12]. Only ferrous heme (FeII) binds O2, ferric heme (FeIII) does not. Therefore globins 
generally possess more positive redox potentials [100 ± 5 mV vs. standard hydrogen 
electrode (SHE) [13]] favoring the stable ferrous state. In contrast, the redox potential for 
peroxidases are typically negative [13]. Another important regulator of O2 binding is the 
distal His that has been found to interact with the bound O2 through an H-bond in most 
globins [7, 14]. 
        Besides the major O2 carrier function, some Mbs exhibit peroxidase-like activities 
under oxidative conditions when the heme iron is oxidized to theferric state [15, 16]. 
Ferric Mb reacts with H2O2 yielding high-valent heme species (Cpds I and II) that oxidize 
the biological molecules involved in oxidative stress reactions [17-20]. The peroxidase 
catalytic path of Mb is generally analogous to that of a typical peroxidase [21-23]. It has 
also been reported that Mb also has nitrate reductase activity in response to hypoxia in 
mammalian cells, which further broadens the functional versatility of globins [24]. 
! 10 
Dehaloperoxidase from A. ornata 
        In 1977, a coelomic Hb was discovered as the most abundant protein in the sea 
annelid Amphitrite ornata [25]. The worm was found buried in coastal mud with a 
reddish color throughout the body (Figure 1.5). Later in 1996, the same protein was 
rediscovered as a dehaloperoxidase enzyme that detoxifies halophenolic metabolites 
secreted by other marine cohabiters such as Notamastus lubatus (eq. 1.4) [26]. The dual 
functional Hb was then named as dehaloperoixdase (DHP) and was the first catalytically 
active globin [27]. Two genes (dphA and dphB) have been found encoding DHPA and 
DHPB respectively [28]. The two isomers only differ at five amino acids. 
                                     (1.4) 
        The crystal structure of DHP A was determined by Lebioda and coworkers in 2000 
[29]. DHP is a dimer containing two identical, but functionally non-cooperative subunits 
(Mr = 15,590). The typical globin-fold of DHP is analogous to that of SW Mb while 
distinct from those of traditional peroxidases such as HRP (Figure 1.6). HRP is twice as 
large as DHP and the two proteins have distinctly different heme environments: HRP has 
the heme buried inside the protein while the heme in DHP is more exposed to the solvent. 
Despite these differences, Mb, DHP and HRP all share a common heme active site 
construct consisting of a heme, a distal His and a proximal His (Figure 1.7). Close 
examination reveals subtle differences among the three. First of all, the distal His is much 
further (6.0 Å) from the heme iron in HRP than that in sperm whale Mb (4.6 Å). This 
longer distance favors H2O2 heterolysis over O2 biding. The DHP has an intermediate  
! 11 
 
        














Figure 1.6 Structural comparison of dehaloperoxidase hemoglobin (DHP, PDB 2QFK), 







Figure 1.7 A comparison of the active sites of sperm whale Mb (pink), DHP (blue) and 












distal His Nε-Fe distance (5.4 Å) which to accomplish both O2 binding and H2O2 
heterolysis [27]. On the proximal side, the rotational angle of proximal His in DHP is 
about 60° rotated clockwise from that in Mb, resulting in new interaction of proximal His 
with peptide carbonyl group that provides a weak electron push [27]. Nevertheless, DHP 
lacks a strong proximal “push” effect that has been seen in typical peroxidases (see 
Figure 1.7) [32]. The proximal His in DHP is neutral like other globins as indicated by 
extensive spectroscopic data [33]. The significantly enhanced (> 250-fold) peroxidase 
activity of DHP compared with Mb is the outcome of both distal and proximal side heme 
environment adaptations during the evolution of DHP from an ancient O2 carrier [27].   
        The DHP catalytic cycle involves two consecutive one-electron oxidations of the 
halophenolic substrates by Cpd ES/Cpd II, yielding halophenoxyl radicals (Figure 1.8). 
The radicals then undergo further oxidation and hydration to form the final quinone 
product [34, 35]. The substrate binding follows the traditional peroxidase order, i.e., H2O2 
binds prior to organic substrate as suggested by extensive rapid-scan stopped flow 
spectroscopic studies [36].  
        A unique structural feature in DHP is the great flexibility of distal His, which has 
two conformations at room temperature. The “closed” conformation resembles that of 
sperm whale Mb while the “open” conformation has the distal His swung out and 
exposed to the solvent (Figure 1.9) [29]. The crystal structure also suggested that the 
“open” conformation associates with the absence of distal H2O while the “closed” His 
forms a hydrogen bond with a H2O molecule that coordinates to the heme iron.  As the 
distal His is involved in the binding/activation of H2O2 as well as in the binding of O2, it 




Figure 1.8. Proposed enzymatic mechanism for the dehalogenation reaction of 













































Figure 1.9. Superposition of heme active sites of Mb (blue) and DHP A (Pink) showing 















binding can modify the distal His conformation by binding internally inside the distal 
pocket or externally at the heme edge. As indicated by both X-ray crystallographic [29, 
37] and resonance Raman spectroscopic [38] studies, small halophenols like 4-
bromophenol (4-BP) bind internally, forcing the distal His to an “open” position and thus 
inhibiting the catalytic activity of DHP. Relatively bigger halophenols, such as 2,4,6-
trichlorophenol (TCP), are found binding either deep inside or at the entrance of the distal 
pocket [39]. The latter is proposed as the binding site of substrate TCP to DHP Cpd I 
[39].  
        DHP has the highest reduction potential [~ 205 mV [40]] among the globins so its 
oxyferrous state is especially stable. However, this is not a favorable characteristic for a 
peroxidase because the catalytic cycle of peroxidases start from the ferric state and 
oxyferrous (also known as Cpd III) DHP is a catalytically inactive species. A paradoxical 
question as to how the O2 carrier state of DHP switches to its enzymatically active ferric 
state needs to be addressed. There is evidence that substrate trihalophenol plays an 
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Sea worm, Amphitrite ornata, has evolved its globin (an O2 carrier) also to serves as a 
dehaloperoxidase (DHP) to detoxify haloaromatic pollutants generated by competing 
species. A previous mutagenesis study by our groups on both DHP and sperm whale 
myoglobin (SW Mb) revealed some structural factors that influence the dehaloperoxidase 
activities (significantly lower for Mb) of both proteins. Using an isocyanide/O2 partition 
constant measurement method in this study, we have examined the effects of these 
structural factors on the O2 equilibrium constants (KO2) of DHP, SW Mb, and their 
mutants.  A clear trend of decreasing O2 affinity and increasing catalytic activity along 
with the increase in the distal His Nε–heme iron distance is observed. An H93K/T95H 
Mb double mutant mimicking the DHP proximal His positioning exhibited markedly 
enhanced O2 affinity, confirming the essential effect of proximal His rotation on the 
globin function of DHP. For DHP, the L100F, T56G and M86E variants showed the 
effects of distal volume, distal His flexibility and proximal electronic push, respectively, 
on the O2 affinity. This study provides insights into how DHP has evolved its heme 
environment to gain significantly enhanced peroxidase capability without compromising 
its primary function as an O2 carrier.!
 
Keywords: Amphitrite ornata dehaloperoxidase (DHP); sperm whale myoglobin (Mb); 







        When the coelomic hemoglobin from the terebellid polychaete Amphitrite ornata 
was discovered in the 1970’s [1], its peroxidase activity was unknown. In the 1990’s, a 
dehaloperoxidase (DHP) enzyme was discovered in the same sea worm that detoxifies 
halophenols in the tidal sediments where it grows. It is the coelomic hemoglobin that 
carries out the DHP activity. Traditional heme-containing peroxidases [2] and globins 
[hemoglobins (Hbs) and myoglobins (Mbs)] [3] have distinct physiological functions: 
catalyzing the H2O2–dependent oxidation versus the reversible binding of dioxygen (O2). 
These protein superfamilies have entirely different folds and are not evolutionally related. 
However, both contain a heme unit bound to the protein scaffold through a proximal 
histidine that serves as a coordinating ligand to the heme iron, leaving the distal side of 
the heme capable of binding peroxide (peroxidase) or O2 (globin). DHP, which is the 
most abundant protein in Amphitrite ornata, carries out both functions as a globin that 
transports and stores O2 and as a peroxidase that detoxifies trihalophenol substrates 
[2,4,6-TXP (X = F, Cl, Br)] (Scheme 1) [4]. Its structure (with very similar folds to Mb 
[5], Figure 2.1 A) and amino acid sequence indicate that DHP have evolved from an 







+ H2O + HX
YY
X = F, Cl, Br
Y = F, Cl, Br, CH3
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        It has been a subject of intense investigations to probe what structural factors enable 




Figure 2.1. Ferric DHP (pink, lighter color) and sperm whale Mb (blue, darker color) X-ray 
structures alignments for entire peptide folds (A) and heme and its environmental amino acids 
that are subject of this study (B) created by superposing the common heme ring atoms. PDB 
accession codes are 1EW6 (DHP) and 1A6K (Mb).  Note that, in panel A, amino acid side 
chains are omitted; in panel B, for the distal His-55 of  DHP, two positions (open and closed) 
are shown. This figure was prepared using Pymol. 
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In a recent study by our group, a mutagenesis approach was utilized to investigate several 
structural factors that influence the peroxidase activity of DHP [10]. For example, the 
importance of the proper position of the distal His relative to the heme iron has been 
found crucial for the peroxidase activity of DHP [10]. DHP has an intermediate distal His 
Nε-Fe distance (5.4 – 5.5 Å) compared to that in Mb (4.3 – 4.5 Å) and horseradish 
peroxidase (HRP) (~6.0 Å) and its dehaloperoxidase activity is also the intermediate of 
the three [10-12]. This position of the distal His in DHP appears to be convenient for 
carrying out both O2 binding in the ferrous protein and acid-base catalysis for O-O bond 
cleavage of the heme iron-bound peroxide by ferric DHP. Several Mb mutants with an 
elongated distal His-Fe distance (G65T, G65I and F43H/H64L Mb) showed enhanced 
dehalogenation abilities [10]. The reversible O2 binding property might also be affected 
by these mutations since the bound O2 in Mb is stabilized by H-bonding to the distal His 
[13-15]. Another distal side factor that could regulate O2 binding in Mb is the steric effect 
of Ile107 (Figure 2.1 B). Replacing I107 in both human and sperm whale (SW) Mbs with 
a bulky Phe has been shown to increase the O2 affinity [16, 17].  In our previous 
mutagenesis study, a L100F DHP variant exhibited a dehaloperoxidase activity that is 
similar to that of the wild type [10].  
        Besides the distal effect, a charge relay mechanism from the proximal side may also 
affect the dual functions of DHP. A M86E mutation in DHP introduces a negatively 
charged residue nearby the originally neutral proximal His and expectedly enhances the 
peroxidase activity of DHP [10, 18]. This mutation could also modify the O2 affinity 
since the charge relay system could stabilize ligand binding by enhancing the π-back-
bonding from the iron to the ligand [19, 20]. Another proximal factor that is crucial for 
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the peroxidase activity of DHP (much higher than that of Mb) is a roughly 60° rotation of 
the proximal His imidazole ring compared with Mb [5, 10] (Figure 2.1 B). The Mb 
double mutant (H93K/T95H) that mimics the rotational position of the proximal His in 
DHP become a much better peroxidase than wild type Mb [10]. Since the rotation of 
proximal His has also been seen to significantly affect O2 affinity in many other heme 
proteins [21, 22], similar effects of the proximal His rotation on the reversible O2 binding 
property of DHP are expected.  
        In this study, the structural factors that influence the dehaloperoxidase acitivities of 
DHP (previous study [10]) have been examined for their influence on the O2-binding 
function of DHP. Both heme distal and proximal side structural and electronic factors that 
influence the O2-binding function of DHP have been examined to elucidate how DHP has 
altered its heme environment to evolutionally gain significantly enhanced peroxidase 
capability for self-protection without compromising its primary function as an O2 carrier. 
In addition, the effects of substrate 2,4,6-trichlorophenol (TCP) and inhibitor 4-
bromophenol (4-BP) binding on the O2 affinities have also been evaluated for both wild 
type and a mutant DHP (T56G, designed with an increased flexibility of distal His) to 
probe their possible role(s) in functional switching of DHP from an O2 carrier (ferrous 
state) to a peroxidase (ferric state).       !
 
MATERIALS AND METHODS 
Materials.  
        All reagents and biochemicals were purchased from Aldrich, ACROS, or Fisher and 
used without further purification except for potassium ferricyanide, which was 
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recrystallized from water. H2O2 stock (10 mM) in deionized water was prepared daily 
from a 30% commercial stock solution and the concentrations were routinely verified by 
UV-visible (UV-Vis) spectroscopic analysis at 240 nm (ε240 = 39.4 M-1cm-1) [23]. 
Trichlorophenol (TCP) and 4-bromophenol (4-BP) stock solutions (100 mM) were 
freshly prepared in a 50/50 (v/v) ethanol/deionized water mixture. 
Mutagenesis and Sample Preparation.  
        The expression vectors (pUC 19) for wild-type and F43H/H64L sperm whale Mb 
were gifts from Prof. Yoshihito Watanabe (Nagoya University). The procedures of 
expression and purification for sperm whale Mb mutants (pUC 19-G65T, -G65I and –
H93K/T95H) and 6×His-taggged DHP A mutants (pET 16b-T56G and M86E) can be 
found in our previous mutagenesis study [10]. The isolated Mb and DHP proteins were 
completely oxidized to the ferric state by addition of a few crystals of potassium 
ferricyanide (Fluka) followed by gel-filtration column chromatography in 100 mM 
potassium phosphate (pH 5) at 4 °C.  Protein concentrations were determined by the 
pyridine hemochromogen method (ε555 = 34.4 M−1 cm−1) [24]. The oxyferrous protein 
was formed by addition of a slight excess of sodium dithionite to the ferric protein, 
followed by aerobic Bio-Gel P6DG (Bio-Rad) desalting column with 100 mM potassium 
phosphate buffer (pH 7) at 4 °C. Deoxyferrous protein samples were prepared in a rubber 
septum-sealed cuvette by addition of a small amount of solid sodium dithionite to a 
thoroughly degassed ferric sample in 100 mM potassium phosphate buffer (pH 7) at 4 °C. 
O2 dissociation equilibrium constant (KO2) determination.  
        O2 dissociation equilibrium constants (KO2) of DHP (or Mb) were determined by the 
method used by Makino and Yamazaki [25] by first measuring a partition constants (KP) 
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for the replacement of the bound O2 in oxyferrous protein by isocyanide ligand (L) (Eq. 
2.2) and then a dissociation constant (KL) for an isocyanide bound deoxyferrous protein 
(Eq. 2.3).  
DHP-O2 + L  DHP-L + O2                                                                        (2.2) 
KP = [DHP-L] [O2] / [DHP-O2] [L] 
    = {[DHP] [O2] / [DHP-O2]} / {[DHP] [L] / [DHP-L]}                     
    = KO2 / KL                                                                                                   
KO2 and KL are defined as follows: 
DHP + L      DHP-L                                                                                  (2.3) 
KL = [DHP] [L] / [DHP-L]                                                                                 (2.4) 
DHP + O2 DHP-O2                                                 (2.5) 
Thus, from Eq. (2)  
KO2 = KL × Kp                                              (2.6) 
        Kp and KL(O2) were determined by step-wise isocyanide titration of oxyferrous (~ 10 
µM) and deoxyferrous (~ 3 µM) DHP/Mb, respectively, in 100 mM potassium phosphate 
buffer (pH 7.0 or 9.0 for one particular case of a Mb mutant) at 4 oC (or ~22 oC for a few 
cases). Two kinds of isocyanide ligands were used in the titration experiments depending 
on proper affinity ranges between the values (Kd) for the O2-bound (Kd  = 10-5 – 10-3 M) 
and deoxyferrous states bound (Kd  = ~10-6 M) of titrated proteins (if the isocyanide 
affinity is too high or too low, its accurate determination would be difficult or practically 
impossible because of large errors or ligand solubility limits, respectively): Isopropyl 
isocyanide (IPIC) was used for titrations of wt-Mb and H93K/T95H Mb; t-butyl 





titration of oxyferrous proteins, 4 mM ascorbate (pH adjusted to a neutral value) and 
bovine liver catalase (0.1 – 0.5 µM based on heme) were added to the sample to prevent 
autoxidation of the heme and ascorbate-caused undesirable reactions [26]. To help 
maintain the O2 concentration constant throughout the titration (< 3 h), the sample were 
bubbled with air through a Pasteur pipette after each addition of ligand. The titration of 
deoxyferrous proteins were carried out anaerobically in the presence of slight excess of 
sodium dithionite in a rubber septum-sealed cuvette and the isocyanide ligands were 
added in a step-wise manner using a gas-tight microliter syringe. 
       Titration spectra were analyzed using a simple biomolecular association scheme and 
the plots of absorbance change vs. ligand concentration were analyzed by a hyperbolic 
regression fit of a saturation plot (absorbance change vs. ligand concentration), giving the 
values of Kp and KL. Three or more sets of Kp and KL were obtained for each titration to 
calculate the final KO2 using Eq. 2.4. The O2 concentrations were considered as 400 µM at 
4 °C and 270 µM at room temperature (~22 °C) [27, 28]. 
Peroxidase Activity Assay 
        UV-Vis absorption spectroscopy was used to measure the peroxidase activity of 
DHP at 4 oC in100 mM potassium phosphate buffer (pH 7.0). TCP were added to the 
ferric enzyme (~3 µM) before addition of hydrogen peroxide to initiate the reactions in a 
0.5-cm cuvette.  The turnover number (kcat) can be measured by monitoring the change in 
absorbance at 272 nm for the appearance of quinone products (ε272 = 14 mM-1cm-1) [29]. 
The kcat values were determined by calculating the velocity (vo) from the initial linear 
portion of the trace at 272 nm as a function of H2O2 concentration with a fixed [TCP], 
followed by a graphical calculation (hyperbolic curve fitting) of a vo value at infinite 
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[H2O2] to obtain a vmax value and then by dividing the vmax by the enzyme concentration 
(kcat = vmax/[DHP]). For each set of reaction conditions, 10 replicates were performed and 
then averaged to determine the velocity at the varying [H2O2] (typically 20 ~ 480 µM) 
and fixed [TCP] (500 µM).  
Spectroscopic Techniques. 
        UV-Vis absorption spectra were recorded with a Cary 400 spectrophotometer 
interfaced to a Dell PC. Magnetic circular dichroism (MCD) spectra were measured with 
a magnetic field strength of 1.41 T by using a JASCO J815 spectropolarimeter equipped 
with a JASCO MCD-1B electromagnet and interfaced with a Gateway PC through a 
JASCO IF-815-2 interface unit. Data acquisition and manipulation were carried out as 
previously described [30].  
Crystallography.  
        The L100F variant of DHP was crystallized in the oxyferrous form (as purified) 
using the vapor diffusion method in hanging-drop set-up. The protein dissolved in 20 mM 
sodium cacodylate pH 6.5 was concentrated to 10 mg/ml. The crystals were grown from 
solutions containing 0.2 M ammonium sulfate and 26-34% polyethylene glycol 4000, as 
previously reported for other DHP mutants [31]. The data set was collected at SERCAT 
22ID beamline at the Advanced Photon Source (APS) in the Argonne National 
Laboratory.  The data were indexed, integrated and scaled with the HKL2000 software 
package. Data collection and processing statistics are listed in Table 2.6. The structure of 
L100F•O2 was determined using molecular replacement with the Phaser program from 
the CCP4 suite of program using the wt-DHP structure (PDB entry 1EW6) as the initial 
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model. Structure rebuilding was carried out using Coot and Turbo and structure 
refinement and map calculation were performed using Refmac5 from the CCP4 [31]. 
 
RESULTS   
        Representative TBIC titration spectra for oxyferrous and deoxyferrous DHP are 
shown in Figure 2.2, A and B, respectively. Analyses of these titrations (shown in the 
insets) yield KL(O2)  (= [O2] / Kp) and KL values of 0.46 mM and 3.63 µM, respectively, at 
pH 7.0 and 4 °C (see Materials and Methods section). The KO2 value of 3.23 µM (= KL × 
Kp) [3.23 ± 0.37 µM, Table 2.1] is calculated from these values (Eq. 2.6).  To evaluate 
the accuracy of our isocyanide/O2 partition constant measurements, we have also 
determined the KO2 values of SW Mb and DHP at ~22 °C using this method (Table 2.5). 
The results for Mb agree with previously reported values [3, 25]. Our KO2 value for DHP 
(7.70 ± 0.45 µM at ~22 °C) is somewhat larger than the one reported by Weber et al. at 
20 °C [1] [KO2 = 5.1 µM, converted from 2.8 mm Hg by KO2 (µM) = 1.82 × KO2 (mm 
Hg), (Section 7.4 in [3]). A probable reason for this difference may be that the KO2 value 
reported by Weber et al. [1] was likely for a mixture of the two isozymes, DHP A and B 
while this O2 affinity study is for DHP A as an extension of our previous investigations 
on DHP A and its mutants that we have prepared [10]. DHP A and DHP B encoded by 
two separate genes. They have very similar structures while only differing in five amino 
acids [4, 32]. DHP B has an almost two-fold higher O2 affinity than DHP A (Sun, S., 
Wang, C., Sono, M., Lebioda, L., Dawson, J.H., unpublished result). 
        Tables 2.1-2.4 show the KO2 values measured (in this study) as well as the 
dehaloperoxidase activities (kcat) for Mb mutants (previous study [10]) and wt-DHP and  
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Figure 2.2. UV-visible absorption spectral changes on TBIC titrations of oxyferrous DHP (A) 
and deoxyferrous DHP (B) in 0.1 M potassium phosphate buffer, pH 7.0 at 4 °C. Oxyferrous 
DHP (2.31 mM) and deoxyferrous DHP (3.34 mM) were titrated by incremental additions of 
0.03, 0.06, 0.11, 0.22, 0.50, 1.05, 2.14, 4.24 mM (oxyferrous DHP) and 0.80, 1.60, 2.40, 3.18, 
3.98, 7.95, 15.90, 31.74, 190.14 mM TBIC (deoxyferrous DHP). Vertical arrows indicate the 
directions of absorbance change. Hyperbolic saturation plot (solid circle) and its regression fit 
(solid line) of the titration data are shown in the insets, where the peak-to-trough absorbance 
change in difference spectra (not shown) (ΔΔA432-412 = ΔA432 - ΔA412, ΔΔA430-414 = ΔA430 - 
ΔA414) are plotted as function of TBIC concentration ([TBIC]). In B, [TBIC] values used are 
[protein-free TBIC] (= [total TBIC] – [protein-bound TBIC]), while in A, [total TBIC] values 
are used since [protein-free TBIC] ≈ [total TBIC].    
!
! 34 
its mutants (new larger values by 1.1 – 3.1 times obtained in this study with higher [TCP] 
= 500 µM vs.150 µM in the previous study [10]). The resulting kcat values for G65T, 
G65I and F43H/H64L Mb mutants increased along with the distal His Nε – heme iron 
distance (Table 2.1) [10]. Conversely, the KO2 values measured in this study show the 
opposite trend, i.e., their O2 affinities decrease as the distal His Nε – heme iron distance 
increases.  
         The L100F DHP variant, in which the distal side Leu100 is replaced with a bulkier 
Phe group, has only a subtle effect in the turnover numbers [10], but exhibits a 3-fold 
higher O2 affinity than the wild type (Table 2.2). The crystal structure of the L100F•O2 
complex was determined (Figure 2.3) and its parameters and refinement statistics are 
listed in Table 2.6. The structure of the L100F•O2 complex shows that Phe100, which is 
located at the back of the cavity, does not form contacts with the bound dioxygen 
molecule nor with the distal histidine (Figure 2.3).         
         Two proximal side mutants, one for DHP and the other for Mb, have also been 
studied. The O2 affinity of M86E DHP, in which a negatively-charged Glu group is 
introduced close to the proximal His89, shows a significant increase by about 5-fold 
while at the same time displacing an approximately three-fold increase in dehalogenase 
activity (Table 2.2), Table 2.3 lists the KO2 value for H93K/T95H Mb, which is design to 
mimic the proximal His plane of DHP that is rotated by 60° compared with that of Mb 
(see Discussion), measured at pH 9.0 (to avoid enhanced autoxidation of its oxy-complex 
at pH 7.0). It should be noted that the O2 affinities of both DHP [1] and Mb[3] are pH-
independent (between pH 6 and 9), i.e., neither protein exhibits a Bohr effect. This Mb  
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Table 2.1. O2 affinities of SW Mbs (wt and mutants) and wt-DHP (this study) in 100 mM 
potassium phosphate buffer (pH 7) at 4 °C and their turnover numbers (kcat, previous 
study [10]) for the oxidative dechlorination with 150 µM TCP and varying H2O2 
concentration in 50 mM sodium acetate buffer (pH 5.4) (Mbs) or 50 mM sodium citrate 
buffer (pH 5.4) (DHP) at 4 °C. 
 
Protein KO2 (µM) 4 °C, pH 7.0a 
Fe-His55 Nε 
distance (Å)b  
kcat (min-1)  
4 °C, pH 5.4a,c  
wt-Mb 0.27 ± 0.01 (1.0) 4.3 19.0 ± 1.7 (1.0) 
G65T Mb 0.39 ± 0.05 (1.4) 4.6 92.0 ± 7.0 (4.8) 
G65I Mb 1.34 ± 0.21 (5.0) 5.1 138 ± 10   (7.3) 
F43H/H64L Mb 6.12 ± 0.60 (23) 5.4 161 ± 9    (8.5) 
wt-DHP 3.23 ± 0.37 (12) 5.4 243 ± 3    (13) 
a The values in parentheses are relative KO2 or kcat vs. those of wt-Mb.  
b PDB accession codes for metaqua (H2O-ligated ferric heme) structures of proteins listed 
in this table: wt-Mb (1A6K), G65T Mb (3O89), G65I Mb (3SDN), F43H/H64L Mb 
(1OFK) and DHP (1EW6).  
c From ref [10].   
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Table 2.2. O2 affinities of DHPs and their turnover numbers for the oxidative 
dechlorination with 500 µM TCP and varying H2O2 concentration in 100 mM potassium 
phosphate buffer (pH 7) at 4 °C.  
 
 
a The values in parentheses are relative KO2 or kcat vs. those of wt-DHP. 
b The kcat values in this table that were obtained in this study using 500 µM TCP are 
larger than the corresponding values determined with 150 µM TCP in the previous study 















Protein KO2 (µM) 4 °C, pH 7.0 a 
kcat (min-1)  
4 °C, pH 7.0 a, b 
wt-DHP 3.23 ± 0.37 (1.0) 25 ± 1.0 (1.0) 
L100F DHP 1.03 ± 0.07 (1/3.1) 20 ± 1.7 (0.8) 







Figure 2.3. Stereoview of the structure (A) and electron densities (B) of the L100F DHP 
A•O2 complex and its heme distal side environment. Phe100 is located deep in the distal 
pocket and does not form contacts with dioxygen or His55. Two positions of His55 are 
stabilized through hydrogen bonding with O2 and a heme propionate.  The final 2FoFc map 
is contoured at a 1 σ level. Somwhat broaden density of the distal O2 atom of the dioxygen 




Table 2.3. O2 affinities of SW wt-Mb and its H93K/T95H mutant (this study) in 100 mM 
potassium phosphate (pH 9) at 4 °C and their turnover numbers (previous study [10]) for 
the oxidative dechlorination with 150 µM TCP and varying H2O2 concentration in 50 
mM sodium acetate buffer (pH 5.4) at 4 °C.  
 
Protein KO2 (µM) 4 °C, pH 9.0a 
kcat (min-1) 
4 °C, pH 5.4 a,b 
wt-Mb 0.33 ± 0.02 (1.0) 19.0 ± 1.7 (1.0) 
H93K/T95H Mb 0.015 ± 0.003 (1/22) 104 ± 13 (5.5) 

















mutant exhibits ~ 20-fold higher O2 affinity than that of wt-Mb, along with ~ 50-fold 
increase in peroxidase activity as reported previously [10]. 
        For the T56G DHP mutant that designed to increase the flexibility of distal His, its 
O2 affinity was measured both in the absence and presence of TCP/4BP. In the absence of 
TCP/4-BP, T56G DHP has ~ 3.4-fold higher kcat and ~2.4-fold lower O2 affinity than the 
wt-DHP (Table 2.4). Upon addition of 2 mM TCP or 4BP, O2 affinity of T56G DHP 
becomes almost two-fold higher and ~1.5-fold lower, respectively (Table 2.4). In 
contrast, addition of either 2 mM TCP or 4-BP barely altered the KO2 of wt-DHP (Table 
2.4).  Note that none of the KL values in Table 2.4 for the affinity of isocyanide ligand 
used in the O2 affinity measurements are significantly affected by added TCP or 4-BP. 
Figure 2.4 (plotted using data in Table 2.7) shows the concentration-dependency of the 
effect of TCP on the O2 affinity of T56G DHP. 
        To understand the different effects of TCP on the O2 affinity of T56G DHP vs. wt-
DHP, the absorption and MCD spectra of TCP-bound ferric T56G DHP were recorded in 
this study (Figure 2.6, red solid line), which closely resemble those of the acetate 
complex of ferric wt-DHP (at pH 5.4, black dotted line in Figure 2.6) and Mb (at pH 7, 
blue dashed line in Figure 2.6), both reported previously [10].  
 
DISCUSSION 
        Here, we consider several steric and electronic factors that influence the O2 affinities 
of DHP as well as Mb using the wild-type proteins and several mutants in the context of 
evolutional heme environment structural adaptations of DHP to its dual functions.  Since 
we can only see the consequence (outcome) of evolutions in the functions and structure  
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Table 2.4. O2 affinities (KO2) of wt-DHP and T56G DHP and turnover numbers (kcat ) for 
the oxidative dechlorination with 500 µM TCP and varying H2O2 concentration (100 mM 
potassium phosphate buffer, pH 7.0, 4 °C). All the values were determined in this study. 
See text for the definitions of KL (isocyanide equilibrium dissociation constant) and KP 
(O2/isocyanide partition constant) for deoxyferrous DHP. 
 
Protein kcat (min-1) KO2 (µM) KL (µM) and Kp  
wt-
DHP 25.0 ± 1.0 
w/o TCP 3.23 ± 0.37 
KL 3.47 ± 0.48 
Kp 0.93 ± 0.06 
+ TCP (2 mM) 3.53 ± 0.24 
KL 3.60 ± 0.19 
Kp 0.98 ± 0.02 
+ 4-BP (2 mM) 2.95 ± 0.04 
KL 3.17 ± 0.32  
  Kp 0.93 ± 0.15 
T56G 
DHP 86.4 ± 6.5 
w/o TCP / 4-BP 7.83 ± 0.83 
KL 0.45 ± 0.03 
Kp 17.40 ± 0.92 
+ TCP (2 mM) 4.23 ± 0.52 
  KL 0.43 ± 0.04 
Kp 9.83 ± 0.82 
+ 4-BP (2 mM) 11.73 ± 0.89 
KL 0.47 ± 0.05  



































Figure 2.4. Effects of TCP concentration (0 – 2 mM) on the O2 affinities (KO2 in 
µM) of T56G DHP vs. wt-DHP in 100 mM potassium phosphate buffer (pH 7.0) at 4 
°C.  The solid line for T56G DHP is drawn by fitting the four data points to a 
hyperbolic regression curve that yields KO2 = 3.4 µM at infinite [TCP] and [TCP] = 
0.68 mM for a half maximum change in KO2 value.  The dashed line for wt-DHP is 
drawn as a straight horizontal line at KO2 = 3.4 µM. 
!
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of wt-DHP, we use here Mb, and in some cases, DHP itself and their heme environmental 
mutants in an effort to trace back and interpret likely function-related structural 
evolutions in DHP. We note although the effects of such mutations within a given system 
(Mb or DHP) may be applicable to the other system, the actual KO2 values of the two 
systems may not necessarily be directly comparable. 
Effects of Fe-Distal His55 Nε Distance 
        DHPA has an almost 10- (or 6-) fold lower O2 affinity (i.e., higher KO2 value) than 
that of SW Mb [3, 25] (or horse heart Mb [3, 33]). This is likely the result of a 
compromise involved in obtaining the peroxidase activity during the evolution of DHP 
while maintaining a functional requirement as Hb. In addition, other physiological factors 
likely also play a role given that human hemoglobin (a tetrameric and allosteric heme 
protein [3]) has approximately 10-fold lower O2 affinity than DHP at about neutral pH. 
Note that Mb itself has a dehaloperoxidase activity that is much lower (~ 8% that of DHP 
at pH 5.4, with TCP as substrate [8]) than that of DHP.   
        One structural factor that contributes to the lower O2 affinity of DHP is almost 
certainly the longer distal His Nε – heme iron distance in DHP compared to that in Mb. In 
our previous study, the dehaloperoxidase activities of G65T, G65I and F43H/H64L Mb 
mutants, all of which have elongated distances (by 0.3 – 1.1 Å) between distal His and 
heme iron, were examined. The resulting kcat values for these mutants increased along 
with the distal His Nε – heme iron distance (Table 2.1) [10]. This is consistent with the 
significantly (× ~6) enhanced peroxidase activity of the F43H/H64L Mb mutants over 
that of wt-Mb and may be true within a certain distance limit (< 6.6 Å, estimated based 
on L29H/H64L Mb, PDB: 10FJ) as found by Watanabe and co-workers [34]. Conversely, 
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the KO2 values measured in this study show the opposite trend. As shown in Table 2.1, 
their O2 affinities decrease as the distal His Nε – heme iron distance increases, This is 
reasonable considering the H-bond formed between the distal His and dioxygen in the wt-
Mb might be weakened in the mutants with the distal His located further from the heme 
center [13-15]. Thus, based on the present results with Mbs, we propose that “the longer 
the heme iron-distal His Nε distance, the weaker the O2 affinity” co-relation exists in 
general for O2-binding heme proteins when other structural and electronic factors are kept 
similar. This finding (Table 2.1) in turn strongly suggests that the longer heme iron-distal 
His Nε distance in DHP than in wt-Mb must have a considerable O2 affinity lowering 
effect even by a factor of an order of magnitude (Table 2.1). However, to maintain its 
primary function as an O2 carrier, such an unfavorable effect may need to be 
compensated for DHP by altering other structural/electronic factors such as those 
described below. Any such adaptations that also involve further enhancement of the 
peroxidase activity would certainly be even more beneficial for DHP. 
Steric Effects in the Distal Pocket  
        The L100F DHP variant, with the volume of the distal cavity reduced by a larger 
side chain amino acid residue, was designed in our previous study as a probe of the TXP 
(X = Br, Cl) substrate binding site of DHP [10]. The structure of this mutant in the ferric 
state has been reported by Plummer et al. [35]. The structure of the L100F•O2 complex 
shows that Phe100, which is located at the back of the cavity, does not form contacts with 
the bound dioxygen molecule nor with the distal histidine (Figure 2.3 A). The increased 
affinity is likely due to entropic factors resulting from the cavity volume reduction 
meaning that fewer disordered water molecules need to be displaced upon O2 binding. 
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Similar conclusions, based on a modeled position of dioxygen, were reached for the 
I107F mutant of human and sperm whale Mbs [16, 17]. Only the subtle difference in the 
turnover numbers for this mutant compared to that for the wild type enzyme suggested 
that the productive binding site of substrate halophenol is not in the distal pocket [31]. It 
is also interesting to test the O2 affinity of this mutant since the analogous I107F Mb 
mutant has been studied as a part of unsuccessful effort to engineer high O2 affinity Mb 
using Ascaris suum globin [16]. As found in this study, the effect is similar, albeit 
stronger, I107F Mb has 1.4-fold higher O2 affinity than wt-Mb while L100F DHP 
exhibits a 3-fold higher O2 affinity than wt-DHP (Table 2.2). Apparently, this type of 
mutation would not be effective in enhancing higher O2 affinity or peroxidase activity for 
DHP.  
Effects of the Electronic “push” from the Proximal His89 
        Dioxygen affinity has been shown to positively correlate with electron density on 
the heme iron [25, 33, 36] and negatively correlated with reduction potential [37]. An 
electronic “push” from the proximal side toward the heme center could promote the 
formation of an Fe3+-O2- -like species and thus hinder the dissociation of O2 from the 
Fe2+-O2 complex. The M86E DHP mutant designed in our previous study has a negative 
charge inserted near the neutral proximal His in the wt-DHP. Subsequently, Franzen and 
coworkers have shown that its redox potential is considerably lowered [from 202 mV to 
112 mV (vs. SHE)] compared to the wild type, confirming the increased electron density 
on the heme iron of this mutant [18]. As expected, the O2 affinity for this DHP mutant 
shows a significant increase by about five-fold while at the same time displaying an 
approximately three-fold increase in dehalogenase activity (Table 2.2). However, DHP 
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did not use this mutational strategy for its functional adaptation, presumably because the 
gains by this alteration may still not be beneficial enough. However, in making such an 
interpretation it should be considered that this mutation was done on DHP, which has 
already an adapted O2 affinity.   
Effect of the Rotational Position of the Proximal His89 
         Comparing the heme coordination structures of DHP and Mb, a roughly 60° 
rotation of the proximal His imidazole ring (Figure 2.5) has been found and is believed to 
play an essential role in the peroxidase function of DHP [5, 10]. This factor might also 
influence the O2 binding ability of DHP as the rotation of the proximal His has also been 
seen to affect O2 affinity in heme proteins [21, 22]. One example is soybean 
leghemoglobin-a (Lba) which exhibits ~20-fold higher O2 affinity than SW Mb. The 
proximal His of Lba is in the “staggered” conformation in which the His plane aligns 
with a line that goes through the center of the two perpendicular intersecting lines going 
through two sets of diagonal pyrrole nitrogen-nitrogen. (Figure 2.7, B). In contrast, the 
proximal His of SW Mb is in “eclipsed” conformation (with the His plane aligning with a 
line that goes through two opposite pyrrole nitrogens) [41]. The “staggered” 
conformation favors ligand binding with higher affinity than the eclipsed one via an 
electronic effect [38, 39]. Therefore this 45° rotation of the proximal His in Lba 
compared to that in Mb is mainly responsible for its much higher O2 affinity [21, 40-42].  
         H93K/T95H Mb was prepared in our previous study for the purpose of mimicking 
the positioning of the proximal His in DHP (vide supra) [10]. Although its crystal 
structure is not presently available, a model based on the DHP structure indicates that the  
! 46 
 
Figure 2.5. Schematic illustration showing the heme environmental structural differences 
between SW-Mb (left), DHP (middle) and HRP (right) in their O2 complexes. In this 
illustration, the differences in their O2 affinities (Mb vs. DHP) and in peroxidase activities 
(Mb, DHP and HRP) are shown to be correlated to the distal His to heme iron distances (black 
dashed lines), proximal His plane rotations relative to the porphyrin plane (Mb vs. DHP) and 
the absence (DHP)/presence (HRP) of the electron ‘‘push’’ (proximal His!heme iron) and 
‘‘pull’’ (from heme iron toward distal Arg) mechanism. Cyan dotted lines indicate hydrogen 
bonds. Note that the Fe-O-O bond angle in the HRP-O2 [47] complex is similar to that in the 
Mb or DHP complex, but looks linear (180°) in this illustration due to the projection angle 
chosen. Also note that O2 binding to ferrous HRP is essentially irreversible, i.e., HRP heme-
bound dioxygen is not dissociable presumably because of its interaction with the positively 
charged distal Arg38 [48]. The PDB access codes for the structures of oxy-Mb, -DHP and 
HRP are 1a6m, 4kjt (this paper) and 1h57 [47], respectively. 
!
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proximal His in this mutant is rotated about 60o from the eclipsed conformation (Figure 
2.7, C vs. A). This is a conformation that favors ligand binding with high affinity. Indeed, 
this mutant exhibits ~ 20-fold higher O2 affinity than that of wt-Mb (Table 2.4), which in 
turn supports the structural model for the mutant, along with ~ 50-fold increase in 
peroxidase activity as reported previously [10] (see also Table 2.4). These remarkable 
increases in both O2 affinity and dehaloperoxidase activity by the H93K/T95H double 
mutation in Mb explain reasonably well why DHP has adapted its proximal His plane to a 
position that is rotated about 60o from the eclipsed conformation (Figure 2.7, C). The KO2 
data obtained in this study give more importance to this rotation, which not only 
markedly increases peroxidase function but also helps maintain moderate O2 binding 
affinity by sufficiently compensating for the weakened O2 affinity as a consequence of 
the longer distal His Nε – heme iron distance.  
Effects of Distal His-55 Flexibility: Oxygen Affinity of T56G DHP and Effects of the 
Substrate TCP and Inhibitor 4-BP   
        As discussed above, the flexibility and location of the distal His55 in DHP are key 
determinants for both O2 binding and enzymatic activity. The Thr56 adjacent to the distal 
His55 is likely to affect the flexibility of the distal His, and thus we would expect to see 
significant effects on the functions of DHP by changing this residue. By replacing Thr56 
in DHP with much smaller-sized Gly that is found in Mb next to the distal His-64 (Figure 
2.1 B), the distal His55 is expected to gain more mobility. Although we could not 
crystallize this mutant and thus its crystal structure is not available, the analysis of the 
molecular dynamics simulations very recently reported indicates that in T56G DHP, the 
distal His is further away from the heme iron and much more flexible than in the wild 
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type [43]. This might explain the ~ 3.4-fold higher kcat for this mutant than wt-DHP 
(Table 2.4). With respect to the O2 affinity for this mutant, the KO2 value is ~2.4-fold 
larger (i.e., the O2 affinity is lower) than that for the wild type (Table 2.4). These results 
are consistent with the trend that “the longer the Fe-Nε distance, the greater the 
peroxidase activity [10] and the lower the O2 affinity (this study)”.  
        Recently, D’Antonio and Ghiladi proposed an mechanism for TCP-triggered DHP 
functional switching from oxy-ferrous globin to ferric peroxidase by H2O2 [9]. In this 
study, an assumption was made that TCP triggers the functional switching by 
destabilizing the bound O2 in the oxy-ferrous DHP. To test this assumption, we examined 
the effect of substrate (TCP) or inhibitor (4-BP) on the O2 affinity of the wt- and T56G 
DHP. As shown in Table 2.4, the addition of either 2 mM TCP or 4-BP barely altered the 
KO2 of wt-DHP. However, the O2 affinity of T56G DHP becomes almost two-fold higher 
and about 1.5-fold lower on addition of 2 mM TCP and 2 mM 4-BP, respectively.  
        The different effects of TCP/4-BP on O2 affinity of these two proteins can be 
partially explained by the following spectrophotometric study probing the TCP binding 
mode to ferric T56G DHP. Firstly, the binding affinity for ferric T56G DHP (pH 7.0, 4 
˚C) is almost 20-fold higher than that of wt-DHP (Kd = ~ 3 µM vs. 58 µM, this study), 
suggesting a different TCP binding mode in T56G DHP than in the wild type. Secondly, 
while TCP binding barely affects the bound distal water ligand of the ferric wt-DHP [10], 
the UV-Vis and MCD spectra of the TCP-bound T56G DHP closely resembles those of 
wt-DHP•acetate complex in the ferric state (Figure 2.6), indicating an anionic oxygen 
ligand instead of water. Since no carboxylate-containing amino acid groups are available 
in the DHP heme vicinity as a candidate to become a heme ligand (distal side Asp54 is 
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located > 10 Å away from the wt-DHP heme iron), the distal ligand in the TCP-bound 
T56G DHP is perhaps the hydroxide ion stabilized by the interaction with the TCP 
hydroxyl group. Such interaction between TCP and heme ligand has also been seen in the 
ferric L100F DHP•TCP complex where a water molecule bound to the heme Fe is also 
found hydrogen bonded to the TCP hydroxyl group [31]. Based on the above findings, we 
propose that the higher O2 affinity of T65G DHP•TCP than T65G DHP observed in this 
study is likely due to the hydrogen bond formed between the TCP hydroxyl group and O2 
ligand, while such a hydrogen bond is absent in the wild type. Further discussion about 
the likely binding modes in the substrate TCP and inhibitor 4-BP complexes of oxy- and 
ferric T56G DHP and L100F DHP mutants vs. wt-DHP is found in the Supplementary 
Information. 
Implications of the Effects of TCP on the O2 Affinity of DHP for the Functional Switch 
Mechanism 
        Our group previously proposed a functional switching mechanism for the conversion 
of DHP from an O2 carrier to a peroxidase that is mediated by TCP radical generated by 
H2O2 and a trace amount of ferric DHP in the oxy-DHP sample [7]. Subsequently, 
D’Antonio and Ghiladi proposed an alternative mechanism [9], in which substrate (2,4,6-
TXP) binding causes a tautomerization of the distal H55 that destabilizes the bound 
dioxygen and thus shifts the equilibrium towards deoxyferrous DHP. Deoxyferrous DHP 
then reacts with H2O2 to form the catalytically active ferryl species Cpd II [9]. Such 
reactions of ferrous heme proteins with H2O2 to yield ferryl species are known [44-46]. 
However, the results demonstrated in this study indicate that the binding of TCP to DHP 
barely affects its dioxygen affinity, suggesting an alternative role of TCP in the functional 
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switching such as a reductant. In fact, we have very recently obtained evidence that 
supports our previous proposal that TCP radicals are indeed involved in the DHP 
functional switching mechanism [7] (S. Sun, M. Sono,  J. Du, J. H. Dawson,  manuscript 
in preparation). 
  
CONCLUSIONS   
        Since the major Hb in the terebellid polychaete Amphitrite ornata was discovered to 
also have a physiological peroxidase activity, studies of the mechanism of this globin-
catalyzed oxidative reaction have been the focus of much attention [8]. As determined in 
this study, DHP has much lower O2 affinity than SW Mb (KO2(DHP) = 3.23 µM vs. KO2(Mb) 
= 0.27 µM at 4˚C), which is reasonable because Mb functions in O2 storage while DHP 
transports O2 as a coelomic Hb [1].  As schematically illustrated in Figure 2.5, we found a 
trend of “the longer the distal His Fe-Nε distance, the greater the peroxidase activity 
(previous study [10]) and weaker the dioxygen binding ability” (this study) for Mb. These 
trends help explain the intermediate globin and peroxidase function of DHP compared to 
HRP and Mb.  On the proximal side of DHP, our results suggest that the rotational 
position of the proximal His89 are quite essential to maintain a proper O2 affinity for its 
Hb function. These results demonstrate how DHP has gained significantly enhanced 
enzymic (peroxidase) capability in its evolutional process for protection from toxic living 
environment without compromising its primary function as an O2 carrier.  
        On another aspect, destabilization of the O2 complex of ferrous wt-DHP (i.e., 
weakening of the O2 affinity) was not seen in the presence of even at millimolar 
concentrations (up to 2 mM) of TCP. These results challenge the newly proposed 
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peroxidase cycle for DHP by D’Antonio and Ghiladi [9] in which the oxyferrous 
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Binding modes for the substrate TCP and inhibitor 4-BP complexes of oxy- and ferric 
T56G DHP and L100F DHP mutants vs. wt-DHP 
    Spectrophotometric titrations for TCP binding to ferric T56G DHP (not shown) and 
wt-DHP (see [S1] for a similar titration) and spectral (UV-Vis and MCD) 
characterizations of the resulting complexes suggest that the two proteins have distinct 
binding modes (positions and locations) for TCP (Figure 2.6). The resulting absorption 
and MCD spectra of TCP-bound ferric T56G DHP (Figure 2.6, red solid line) closely 
resemble those of the acetate complex of ferric wt-DHP (at pH 5.4, black dotted line in 
Figure S1) and Mb (at pH 7, blue dashed line in Figure S1), both reported previously 
[S1]. Furthermore, the binding affinity for the TCP complex of T56G DHP (pH 7.0, 4 ˚C) 
is found to be extremely high (Kd = ~ 3 µM, this study).  
    Previously, two modes of TCP binding were observed in crystallographic studies: one 
“internal”, deep within the distal cavity, the other “external” with a TCP molecule 
blocking access to the distal cavity and hindering ligand binding to the heme iron [S3]. 
Both TCP binding modes are different from the 4-XP binding mode [S4]. The TCP 
binding mode observed in crystals depended on DHP mutant studied and even in some 
cases was different in the subunits of the DHP dimer. On the other hand the very high 
TCP concentration used, 200 mM (in 50/50 v/v water/ethanol), makes it unlikely that 
another TCP binding site in the studied proteins (DHP, Y34N, Y34N/S95G and L100F) 
exists [S3]. At lower concentrations, such as 2 mM, TCP binding in crystals was below 
the observation threshold.  TCP functions as a substrate with a KM of about 0.5 mM 
because its affinity for Compound I is higher than for DHP [S3]. Similar conclusion was 
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reached for Mb based on inhibition studies of its dehaloperoxidase activity by phenol 
[S5]. Ferric T65G DHP has TCP affinity much higher than any other DHP variant studied 
so far. It is highly unlikely that the TCP mode of binding is external because this mode 
locks the dioxygen binding site while T65G oxygen affinity in the presence of TCP is 
higher than in its absence. Much more plausible is that T65G DHP•TCP complex 
resembles L100F DHP•TCP and wt DHP•TBP complexes in which the internal binding 
mode is observed [S3, S6].  
    The L100F•TCP structure allows more in depth mechanistic analysis because the TCP 
occupancy is high while in the reported DHP•TBP structure it is low, only 10%. In the 
L100F DHP•TCP complex there is a water molecule bound to the heme Fe and hydrogen 
bonded to the TCP hydroxyl. Although there is some overlap of the TCP hydroxyl 
positions in L100F DHP•TCP and the position of the distal atom of the dioxygen 
molecule in the reported here L100F DHP•O2 structure (Figure 2.5), only a minor 
adjustment of the TCP position or tilting the O2 molecule is needed to eliminate the 
hindrance. Also, the likely hydrogen bond between the hydroxyl and dioxygen can 
explain the higher O2 affinity of T65G DHP•TCP than T65G DHP as observed in this 
study, the assumption that the T65G•TCP complex is similar to the L100F DHP•TCP 
complex would suggest a water molecule as the distal ligand in the ferric state. 
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Table 2.5. O2 affinities of wild-type Sperm Whale Mb and DHP in 100 mM potassium 
phosphate buffer (pH 7.0) at 4 °C and ~ 22 °C.  
 
Protein KO2 (µM) 4 °C, pH 7.0 
KO2 (µM) 
~ 22 °C, pH 7.0 
WT Mb 0.27 ± 0.01 0.83 ± 0.06  























    L100F•O2 
    4kjt 
X-ray source APS ID 22 
Wavelength (Å) 1.000 
Number of Frames 180 
Oscillation Range (degree) 1.0 
Temperature (K) 100 
Space group P212121 
Unit cell dimensions a (Å) 59.128 
b (Å) 67.782 
c (Å) 68.132 
Volume (Å3) 273061 
Mosaicity (deg.) 0.45 




Redundancy  (highest shell) 6.9 (4.7) 
Average I/σ(I) 15.0 
Total number of reflections 342270 
Number of unique reflections 47333 
Completeness (%)  (hi. shell) 98.3 (68.9) 
Total linear R-merge (hi. shell) 6.4 (33.2) 
R-value (%)    (highest shell) 13.3 (19.0) 
Rfree -value (%)  (highest shell) 18.0 (26.7) 
Ramachandran statistics 
% of residues 
 
In most favored regions 94.0 
In additional allowed 6.0 
In generously allowed 0 
Average B factor for protein 








Table 2.7 Effects of TCP on O2 affinity of T56G DHP in 100 mM potassium phosphate 
buffer (pH 7.0) at 4 °C. See the main text for the definitions of KL (isocyanide 
equilibrium dissociation constant) and KP (O2/isocyanide partition constant). 
 
[TCP], mM KO2 (µM) 4 °C, pH 7.0 
KL (µM) and Kp  
4 °C, pH 7.0 
0.0 7.83 ± 0.83 
KL 0.45 ± 0.03 
Kp 17.40 ± 0.92 
0.4 6.17 ± 0.72  
KL 0.46 ± 0.02 
Kp 13.42 ± 0.77 
0.8 5.60 ± 0.33 
KL 0.47 ± 0.02 
Kp 11.92 ± 0.98 
2.0 4.23 ± 0.52 
KL 0.43 ± 0.04 





Figure 2.6 MCD (top) and UV-Vis (bottom) absorption spectral of TCP-bound ferric 
T56G DHP (red solid line, 0.8 mM TCP) in 0.1 M potassium phosphate buffer pH 7.0, 
acetate-bound ferric DHP (black dotted line, 82 mM acetate) in 50 mM sodium citrate 
buffer pH 5.4 (re-plotted from [S1]), acetate-bound ferric Mb (blue dashed line, 6 M 
sodium acetate) in 0.1 M potassium phosphate buffer pH 7.0 (re-plotted from [S1]) and 











Figure 2.7 Proximal histidine rotational positions in (A) SW Mb, (B) Soybean 
leghemoglobin (Lba) and (C) DHP. The dashed line is parallel to the plane of His ring 
(which is positioned perpendicular to the porphyrin plane, i.e., the plane of this paper), 



























Evidence for Direct Involvement of Substrate TCP Radical in Functional 
Switching from Oxyferrous O2 Carrier to Ferric Peroxidase in the Dual 















ABSTRACT    
The coelomic dioxygen binding hemoglobin dehaloperoxidase (DHP) from the sea worm 
Amphitrite ornata is a dual function heme protein that also possesses a peroxidase 
activity. Two different starting oxidation states are required for reversible O2 binding 
(ferrous) and peroxidase (ferric) activity bringing into question how DHP manages the 
two functions. In our previous study, the co-presence of substrate 2,4,6-trichorophenol 
(TCP) along with H2O2 was found to be essential for activation of the enzymatically 
inactive oxyferrous DHP (oxy-DHP) state. Based on that study, a functional switching 
mechanism involving substrate radicals (TCP•) was proposed. To further support this 
mechanism, herein we report details of our investigations into the H2O2-mediated 
conversion of oxy-DHP to the ferric state triggered by both biologically relevant [TCP, 4-
bromophenol (4-BP)] and non-relevant (ferrocyanide) compounds. We also find that all 
of these conversion reactions are completely inhibited by the presence of ferric heme 
ligands (KCN, imidazole), indicating an involvement of the ferric oxidation state. 
Furthermore, the spin-trapping reagent 5,5-dimethyl-1-pyrroline-N-oxide (DMPO) 
effectively inhibits the TCP/4-BP (but not ferrocyanide)-triggered oxy- to ferric 
conversion of DHP. Taken together, the results demonstrate that substrate TCP triggers 
the activation of oxy-DHP into a catalytically active peroxidase through direct oxidation 
by TCP radicals that are generated and start to accumulate upon H2O2-oxidation of TCP 
catalyzed by trace amounts of ferric DHP initially present in the oxy-DHP sample. The 
data presented herein further address the mechanism of how the halophenolic substrate 




!!!!!!!!Dehaloperoxidase (DHP) from the terebellid polychaete Amphitrite Ornata is a dual-
functional dioxygen-binding hemoglobin that also exhibits peroxidase activity. As the 
most abundant protein in this worm [1], DHP mainly functions as an O2 carrier globin. It 
is isolated in the oxyferrous state [1] and has a moderate O2 affinity (KO2) at 5.1~7.7 µM 
(22 °C) [2, 3]. As a peroxidase, ferric DHP catalyzes the H2O2-dependent oxidative 
dehalogenation of 2,4,6-trihalophenol (TXP) substrates to the corresponding 2,6-
dihaloquinone (DXQ) (where X = Cl and Br), providing A. ornata with protection against 
toxic halophenols that are excreted by another inhabitant, Notomastus lobatus, in its 
living environment [4, 5]. The dehaloperoxidase reaction mechanism is similar to that of 
horseradish peroxidase (HRP)- or chloroperoxidase (CPO)-catalyzed oxidation that 
involves two consecutive one-electron oxidations of TXP to TXP radical by two high-
valent (ferryl) oxidants Cpd I/ Cpd ES and Cpd II (Scheme 3.1) [6-12]. The TXP radicals 
generated in the catalytic cycle then form the final product DXQ, possibly by either 
disproportionation or further enzymatic one-electron oxidation of the radicals, followed 
by hydration [13, 14]. Kinetic studies have shown that at pH 5.4, DHP catalyzes 
dechlorination of 2,4,6-trichlorophenol (TCP) at rates (kcat) ~33 times slower than HRP 
but ~13 times faster than myoglobin (Mb) [4, 15]. The moderate peroxidase activity of 
DHP arises from several structural adaptations it has acquired during its evolution from 
an ancient O2 carrier with its proximal neutral histidine conserved [3, 16-18]. Besides 
TXP, the much less toxic monohalophenols (4-XP) are co-present in the A. ornata 




Scheme 3.1. Catalytic cycle for the peroxidase-catalyzed oxidative dehalogenation of 







































for substrate TCP catalysis [21], it has been recently shown that 4-BP itself is also 
oxidized by DHP with slow yet measurable turnover [22]. DHP has two isozyme forms, 
DHP A and DHP B, encoded by two separate genes. They have very similar structures 
while only differing in five amino acids [1, 23, 24]. This study will focus on DHP A. 
        A major question arises as to how DHP will interconvert the different oxidation 
states of the heme required by these two functions, i.e., the ferrous state for the O2 carrier 
role vs. the ferric state for the peroxidase activity. It has been shown that DHP can switch 
from the oxyferrous state to the ferric state via H2O2-oxidation, but this only occurs when 
substrate trihalophenol is present [25, 26]. The triggering mechanism has been disputed 
by two research groups. Our lab has proposed a direct oxidation of the oxyferrous heme 
to the ferric state by substrate TCP radicals (TCP•) that are initially generated via 
oxidation of TCP by the peroxidase reaction of H2O2 in the presence of trace amounts of 
ferric DHP that exist in the oxyferrous protein sample [25]. Analogous results and 
mechanistic interpretations have been previously reported for the role of substrate 
radicals in the conversion of lignin peroxidase compound III (non-physiological 
oxyferrous state) to the active ferric enzyme [27, 28] On the other hand, Ghiladi and co-
workers subsequently proposed that conversion of the ferrous state to the catalytically 
active species Cpd II initiated by H2O2 replacing the bound-O2 upon substrate binding 
[26]. The latter mechanism is built on the experimental observation that Cpd II can be 
formed directly from deoxyferrous DHP by reaction with H2O2 alone [26]. However, 
such a reaction has only been demonstrated under anaerobic conditions. With O2 bound 
to the ferrous heme, Cpd II DHP can not be formed upon addition of H2O2 [25, 26]. The 
lack of reactivity of oxy-ferrous DHP towards H2O2 in the absence of TXP may have 
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physiological significance since DHP primarily functions as an oxygen transport protein. 
The hypothesis of Ghiladi and co-workers that TCP binding triggers the formation of Cpd 
II by promoting the replacement of bound O2 with H2O2 has been challenged by our 
recent O2 affinity (KO2) study of DHP in which we reported that the KO2 value of DHP is 
barely affected by the presence of TCP [3].  
        To clarify the unsettled functional switching mechanism of DHP, i.e., the H2O2-
mediated oxidation of oxyferrous to ferric DHP, we have further probed the role of TCP 
in activating the peroxidase function from the O2-carrying ferrous state of DHP.  We 
have found that not only the substrate TCP and inhibitor/substrate 4-BP, but also a 
structurally totally unrelated redox compound ferrocyanide, a known peroxidase substrate 
[29]. can trigger the functional switch. Furthermore, we have demonstrated that the ferric 
heme ligands imidazole (Im) and cyanide (CN-) as well as a spin-trapping reagent 5,5-
dimethyl-1-pyrroline-N-oxide (DMPO) each alone can completely inhibit the TCP-
triggered conversion of oxyferrous to ferric DHP. These and additional data shown in this 
study are consistent with a direct oxidation of oxy-DHP to the ferric state by TCP 
radicals as the initial step in the activation of oxy-DHP for peroxidase function.  
MATERIALS AND METHODS 
        Materials. Reagent-grade chemicals (Aldrich, ACROS, Cayman, or Fisher) were 
used without further purification. HRP (type VI, Rz 2.7) was purchased from Sigma-
Aldrich. Wild-type six-His-tagged DHP was expressed and purified as previously 
described [30]. Protein concentrations were determined by the pyridine hemochromogen 
method (ε555 = 34.4 M−1 cm−1) and are the concentrations of the heme component. 
Homogeneous oxyferrous DHP was generated by addition of a slight excess of sodium 
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dithionite to isolated DHP followed by Biogel P6DG (BioRad) desalting column 
chromatography with 0.1 M potassium phosphate buffer (pH 7) at 4 °C [25]. 
        All stock solutions of chemicals were freshly made before experiments. 
Concentration of H2O2 diluted from a 30% stock solution was confirmed 
spectrophotometrically (ε240 = 39.4 M−1 cm−1) [31]. TCP and 4-BP stocks (10 mM) were 
made in a 50/50 (v/v) ethanol/deionized water mixture.  
        Stopped-Flow UV-visible Spectrophotometric Studies. Transient reactions and 
the detection of enzyme intermediates were performed on a stopped-flow 
spectrophotometer (1.0 cm path length, model SF-61 DX2; Hi-Tech Scientific, Salisbury, 
U.K.) at 4 °C in 100 mM potassium phosphate buffer (pH 7.0) in the single-mixing mode. 
The double-mixing mode has also been used only for generation of Cpd ES DHP and its 
reaction with substrates: Fe(III) DHP is first mixed with 1.2 equiv. H2O2 allowing for 
Cpd ES to be fully formed (age time, 15 s) and then mixed with substrates. Oxyferrous 
DHP at a final concentration of 5 µM alone or containing TCP, 4-BP or ferrocyanide was 
mixed with 1 or 5 equiv. of H2O2. Global analysis was performed using the Specfit 
Global Analysis software and fit to exponential functions as a two-step, three species 
irreversible mechanism.  
        Bench-top Mixing Kinetics Assays. The inhibition reactions were monitored using 
a Cary 400 UV-visible spectrophotometer in a 1.0 cm path length cuvette at 4 °C. The 
oxy-DHP concentration in each sample was 5 µM in 100 mM potassium phosphate buffer 
(pH 7.0). The substrates (TCP, 4-BP or potassium ferrocyanide) and inhibitors (Im or 
CN-) were first mixed with oxy-DHP in phosphate buffer (total volume 0.7 ml) and 
incubated for 3 min in the cuvette. Subsequently, H2O2 solution (a few µl) was added to 
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the cuvette to initiate the reaction. 
        GC-MS Analyses. A HP-5890 Restek RTX-5 GC capillary column (30 m × 0.32 
mm) was used for detection of the products extracted from aqueous solution by ethyl 
acetate. The initial temperature of the column was set at 50 °C for 2 min, and the 
temperature was subsequently increased at a rate of 10 °C/min up to a final temperature 
of 300 °C and held for 10 min. MS detection was in the electron impact (EI) ionization 
mode, and a VG70S mass spectrometer scanning from 50 to 450 amu was used for 
product identification.  
RESULTS 
        TCP/H2O2-triggered conversion of oxy-DHP to the ferric state. In our previous 
study, we demonstrated that conversion of oxy-DHP (5 µM) to the ferric enzyme requires 
co-presence of the substrates TCP and H2O2 using excess TCP (150 µM, 30 equiv.) and 1 
or 0.5 equiv. of H2O2 [25]. During the conversion, an absorption spectral change with a 
single set of isosbestic points (412, 528, 592 nm) was observed, suggesting that no 
detectable intermediates are involved. To further probe the conversion mechanism, we 
have performed more detailed investigations in this study on the activation reaction with 
[oxy-DHP]:[H2O2]:[substrate] = 1 : 1 : 1. Figure 3.1A shows that in the presence of 1 
equiv. of TCP, 1 equiv. of H2O2 readily converts oxy-DHP [417 (Soret), 542 and 578 nm] 
to the ferric state [407 (Soret), 503 and 635 nm] within 450 s reaction time. Under these 
conditions, the spectral changes exhibit three sets of isosbestic points indicating that 
another enzyme species is involved as an intermediate during the conversion.  
        The three sets of isosbestic point in Figure 3.1A are nearly identical to those for oxy-
DHP/Cpd ES (394, 586 nm), Cpd ES/ferric (414, 611 nm) and oxy-DHP/ferric DHP 
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(412, 591 nm) based on overlaid normalized absorption spectra of these three DHP 
species (Figure 3.6A), indicating that ferryl DHP is formed as an intermediate in the 
reaction. The difference between the isosbestic point seen at 394 nm for oxy-DHP/Cpd 
ES in Figure 3.6A and the actual isosbestic point at 404 nm in the time-dependent 
spectral changes (Figure 3.1A) can be explained by simulated spectral changes for the 
three DHP forms (Figure 3.7B) that yield a shifted (394 to 404 nm) position for this 
particular isosbestic point. This shift is probably observed because of the less than 
stoichiometric formation of ferryl DHP. The formation of the ferryl intermediate is also 
supported by the global analysis result for the above reaction as shown in Figure 3.1B 
[absorption peaks at 420 (Soret), 545 and 583 nm, green solid line], whose maximum 
amount reaches only ~45% of the total DHP concentration. 
        Based on the above assignment, the time-dependent absorption changes at two 
observed Soret isosbestic points (at 414 nm for Cpd ES/ferric DHP and 405 nm for oxy-
DHP/Cpd ES) could represent the time-dependent disappearance of oxy-DHP (green 
diamond) and the appearance of ferric species (black circles), respectively, as shown in 
the Figure 3.1A, left panel inset. These spectral changes are coupled with the rise 
(absorption decrease) and decay (absorption increase) of the ferryl intermediate as 
indicated by the absorption changes at 412 nm, an isosbestic point for oxy-DHP/ferric 
DHP as a function of time (blue triangles in Figure 3.1A, left panel inset). A similar 
result in the visible region at 591 nm was also observed for the appearance (first phase) 
and disappearance (second phase) of the ferryl intermediate (blue triangles) as well as at 
586 nm for the rise (absorption decrease) of ferric DHP (Figure 3.1A, right panel inset, 























































































































Figure 3.1. (A) Spectral change upon addition of 5 µM H2O2 to 5 µM oxyferrous DHP 
in the presence of 5 µM TCP.  The insets in panel A show time-dependent absorbance 
changes at particular isosbestic points indicated to monitor disappearance of oxy-DHP 
(green diamonds), appearance of ferric DHP (black circles) and rise and decays of 
ferryl (Cpd ES) DHP (blue triangles). The red bold lines on the traces show 
exponential fits for the indicated time ranges and calculated apparent first-order rate 
constants. (B) UV-visible spectra of oxyferrous (red solid line), ferryl (green solid 
line) and ferric (blue dashed line) DHP obtained from global analysis of the data in 
panel A. The inset in panel B shows the relative concentration profile determined by 
the global analysis.  
!
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part (bold red lines) of these absorption changes for oxy-DHP disappearance [(2.3 ± 0.1) 
× 10-2 s-1 (A414)], ferric DHP appearance [(8.4 ± 0.1) × 10-3 s-1 (A405) or  (9.4 ± 0.2) × 10-3 
s-1 (A586), both considered practically identical], ferryl DHP appearance [(2.7 ± 0.1) × 10-
2 s-1 (A591)] and ferryl DHP disappearance [(1.2 ± 0.1) × 10-2 s-1 at (A591)]. Even though 
these kobs values were obtained under the non-pseudo-first-order reaction conditions, the 
reaction traces nicely fit exponential decays or emergences of the three species and thus 
these values can provide a convenient way to estimate the true second-order rate 
constants (k) based on kobs = ~ k[TCP]o or ~ k[H2O2]o, where [TCP]o and [H2O2]o are the 
initial concentrations of TCP and H2O2, respectively [32]. The kobs values thus obtained 
may be useful, in evaluating the relative rates among different reactions in order to 
interpret the reaction mechanisms as done in this study. Note that the rise of the ferryl 
DHP species starts slowly with an apparent lag time period before its formation rate 
reaches a maximum (see Figure 3.1A insets, blue triangles) suggesting that there is yet 
another species is being formed prior to the formation of ferry l DHP (vide infra).  
    H2O2-mediated conversion of oxy-DHP to ferric DHP triggered by 4-BP or 
ferrocyanide / ferricyanide. Reactions of oxy-DHP with H2O2 in the presence of 4-BP 
are shown in Figure 3.2A. The maximum activation rate in the presence of excess 4-BP 
(150 µM) is (2.3 ± 0.1) × 10-2 s-1, which is as fast as the conversion triggered by 1 equiv. 
of TCP [(2.3 ± 0.1) × 10-2 s-1, Figure 3.1A]. In the presence of only 1 equiv. of 4-BP, the 
rate is considerably slower [(6.9 ± 0.5) × 10-3 s-1, Figure 3.7A] compared with TCP by 
~3.4-fold. Underivatized phenol is also able to induce the H2O2-oxidation of oxy-DHP at 
a comparable rate [(3.1± 0.1) × 10-2 s-1, at 150 µM, Figure 3.7B].     
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Figure 3.2. Spectral change upon addition of 5 µM H2O2 to 5 µM oxyferrous DHP in 
the presence of (A) 150 µM 4-BP or (B) 5 µM potassium ferrocyanide.  The insets in 
the top part of both panels show the time-dependent absorbance changes at selected 
isosbestic points to monitor the disappearance of oxy-DHP [417 nm (A) and 414 nm 
(B)], or the appearance of ferric DHP [408 nm (A) and 405 nm (B)]. The gray bold 
lines on the traces show exponential fits for the indicated time ranges.  Apparent first-
order rate constants (kobs) obtained from the fits are 2.3 × 10-2 s-1 (A417) and 1.9 × 10-2 
s-1 (A408) in panel A and 4.8 × 10-2 s-1 (A414) and 1.0 × 10-2   s-1 (A405) in panel B. 
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Surprisingly, ferrocyanide, a known peroxidase substrate[29] with a structure that is 
totally different from DHP substrates, can also trigger the functional switch of oxy-DHP. 
Figure 3.2 B shows that in the presence of 1 equiv. of ferrocyanide, oxy-DHP quickly 
switches to the ferric state upon reaction with 1 equiv. H2O2. The spectral change for 
ferrocyanide-triggered conversion of oxy-DHP is not significantly different from that for 
TCP-triggered one, except that the rate is about twice greater [(4.8 ± 0.2) × 10-2 s-1 vs. 
(2.3 ± 0.1) × 10-2 s-1] under the same conditions. A similar conversion has also been seen 
in the presence of another structurally unrelated compound, potassium iodide (KI), but 
only at acidic pH (data not shown).  In fact, iodide is known to be a reductant (substrate) 
for HRP Cpd I preferably at acidic pH values [12]. The apparent conversion rates, kobs 
values, of oxy-DHP triggered by various substrates discussed here are listed in Table 3.1.  
        TCP and ferrocyanide presumably trigger the switch of oxy-DHP to the ferric state 
by serving as peroxidase substrates for the trace amount of ferric DHP in the oxy-DHP 
sample in the presence of H2O2. This would then generate TCP radical (TCP•) and 
ferricyanide, respectively, which, in turn, would serve as an oxidant to convert oxy-DHP 
to the ferric state. Thus, ferricyanide would serve the same role as TCP• in the switching 
mechanism. To directly test this hypothesis, we have monitored the spectral change for 
the reaction of oxy-DHP with 1.0 equiv. ferricyanide (in place of ferrocyanide) and 1.0 
equiv. H2O2 as shown in Figure 3. Similar to the cases with TCP (Figure 3.1A) and 
ferrocyanide (Figure 3.2B), three sets of isosbestic points are observed as shown in 
Figure 3A and assigned to those for oxy-DHP/Cpd ES (586 nm), Cpd ES/ferric (414, 611 
nm) and oxy-DHP/ferric DHP (412, 591 nm). Thus the change of oxy-, ferryl and ferric 
DHP species can be represented by the time course traces for 611, 591 and 586 nm,  
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Table 3.1. Apparent first-order reaction rate constants (kobs) for conversion of oxy-DHP 
to ferric DHP triggered by various peroxidase substrates at pH 7.0, 4 °C. All rates are 
determined by analyzing the time-dependent absorbance changes at 414 (TCP and 
ferrocyanide) or 417 nm (4-BP and phenol) for the disappearance of oxy-DHP. 
Concentrations for oxy-DHP, H2O2 and substrates are all 5 µM. 
Substrate    kobs (s-1)  
 TCP (2.3 ± 0.1) × 10-2 
 4-BP (6.9 ± 0.5) × 10-3 
 Phenol (3.1 ± 0.1) × 10-2 
















Figure 3.3. (A) Spectral change upon addition of a mixed solution of 5 µM H2O2 and 5 
µM potassium ferricyanide to 5 µM oxyferrous DHP for time periods of 0 – 25 s (dark 
pink) and 25 – 300 s (green). (B) Time-dependent absorbance changes at particular 
isosbestic points in panel A to monitor disappearance of oxy-DHP (A611, red stars), 
appearance of ferric DHP (A586, blue triangles) and rise and decays of ferryl (A591, Cpd 
ES) DHP (black circles). The dashed lines on the plots show exponential fits for the 
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respectively, as shown in Figure 3B. Different from the conversion reaction with 
ferrocyanide, the reaction with ferricyanide (blue triangles) consists of a fast phase (0 - 
25 s, enlarged in the bottom panel of Figure 3B), followed by a slow phase (75 - 300 s, 
Figure 3B, top). In the fast phase (Figure 3B, bottom), ferric DHP is formed before 
formation of ferryl DHP as indicated by the decrease of Abs586 to the nearly constant 
value (blue triangles) vs. the little change of Abs591 (black circles for ferryl DHP) for the 
first ~5 s. After ferric species stops accumulating, ferryl DHP starts to arise until it 
reaches its maximum amount at the end of the fast phase (~25 s). At a later stage (75 - 
300 s), ferryl DHP decays (black circles) concomitant with further formation of ferric 
DHP (blue triangles) at a rate of ~0.008 s-1. The bimolecular rate constants for the step of 
ferricyanide oxidizing oxy-DHP to the ferric state as well as for other steps involved in 
the reaction above have been separately determined using a stopped-flow technique in 
this study and are listed in Table 3.2 (see Discussion section).  
!!!!!!!!Inhibitory effects of ferric heme protein ligands and spin trap reagent DMPO on 
the functional switching of oxy-DHP. In our previously proposed functional switching 
mechanism for DHP, it was speculated that the peroxidase activity of a trace amount of 
Fe(III) enzyme is critical in initiating the conversion by generating TCP• as an oxy-DHP 
oxidant. To further test this proposed mechanism, reagents that bind to and thereby 
inhibit the activity of the ferric enzyme or that trap the TCP radicals were added to the 
oxy- to ferric DHP conversion reaction. Cyanide (KCN) and imidazole (Im) are both 
ferric heme ligands (Kd values for their complexes with ferric DHP at pH 7.0 and 4 °C 
were ~0.5 µM for cyanide and ~0.2 mM for Im, this study) and they have much weaker 
affinities for the ferrous heme proteins [e.g., Kd = 10-1 – 100 M (cyanide) [33] and 10-1 -  
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Table 3.2. Bimolecular rate constants for the reactions indicated in Scheme 3.2; k1, k2 and 
k4 are for the reactions of oxy-DHP with ferricyanide (k1), ferric DHP with H2O2 (k2), and 
DHP Cpd II with TCP, 4-BP or ferrocyanide (k4). Apparent first-order reaction rate 
constants (kobs) obtained from the time-dependence spectral change of DHP upon reacting 
with various concentrations of substrates or oxidants (from 1 up to 10 equiv.) were 
plotted vs. [substrate/oxidant] and the bimolecular rate constants (k1 – k4) were calculated 
from the linear correlations (see Figure 3.11 for representative examples).   
Substrate/oxidant 
   Rate constants (M-1s-1) 
pH 7.0, 4 °C 
 Ferricyanide k1         (4.6 ± 0.4) × 104 
 H2O2 k2         (3.5 ± 0.1) × 104 
 TCP k4        (9.4 ± 0.3) × 102 
4-BP k4         (9.7 ± 0.9) × 102 













Figure 3.4. UV-visible spectroscopic monitoring upon addition of 5 µM H2O2 to a 
mixture of 5 µM oxy-DHP and (A) 20 mM Im or (B) 5 mM KCN in the presence of 5 
µM TCP during a period of 0 - 600 s and upon subsequent addition of 25 nM HRP at 
time 600 s (0.005 equiv., 0.5%) during a period of 600 to 800 s. The black circles in the 
insets show the plots of absorbance at 578 nm (A578) as a function of time. The black 
dashed lines are straight lines drawn through the black circles and the solid line (600 – 
800 s in panel A) is the fit to an exponential decay curve which yield an apparent first-







101 M (Im) [34] or deoxyferrous Mb at pH 7.0]. As shown in Figure 3.4, both Im (20 
mM, panel A) and KCN (5 mM, panel B) are able to totally inhibit the TCP-triggered 
conversion of oxy-DHP, as indicated by the absence of absorption changes at 417 nm 
(Soret peak) upon addition of H2O2 and TCP to oxy-DHP (0 - 600 s). Inhibition by CN- 
or Im was also observed in the ferrocyanide-triggered conversion of oxy-DHP (Figure 
3.8). In addition, inhibition by Im can be reversed by adding a small amount of HRP 
(0.5%, 25 nM), which generates TCP radicals by catalyzing the TCP oxidation by 
H2O2.[4, 13] As shown in Figure 3.4A (600 - 800 s), addition of HRP results in the 
transformation of oxy-DHP [417 (Soret), 542, 578 nm (red solid line)] to Fe(III)-Im DHP 
complex [415 (Soret), 538 nm (red solid line)] (k = 0.009 s-1). On the other hand, addition 
of HRP (0.5%, at 600 s) to the CN--inhibited oxy- to ferric DHP conversion had little 
effect (Figure 3.2.4B). This is due to the fact that ferric HRP has a very low affinity for 
Im (negligible binding at 20 mM, this study), but has a high affinity for cyanide [tight 
binding with Kd = (2.5 – 3.0) × 10-6 M at pH 7] [35] and thus the peroxidase activity of 
HRP was completely inhibited in the presence of CN- (5 mM). 
        Next, to directly prove the involvement of TCP radicals in the functional switch of 
oxy-DHP, the spin-trapping reagent DMPO (see Supporting Information for its structure) 
that potentially traps TCP radicals was introduced to the switching process. A complete 
inhibition of the TCP- or 4-BP-triggered conversion of oxy- to ferric DHP by 10 mM 
DMPO was observed as shown in Figure 5. Such inhibition was also observed with 
increased [H2O2] to 5 equiv. (25 µM), but more DMPO (50 mM) was needed to achieve 
the complete inhibition (Figure 3.9). Attempts to detect and identify the trapped product 
(DMPO-TCP radical) by GC-MS were not successful, probably due to the likely low  
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Figure 3.5. UV-visible spectroscopic monitoring upon addition of 5 µM H2O2 to the 
mixture of 5 µM oxy-DHP and 10 mM DMPO in the presence of (A) 5 µM TCP, (B) 150 
µM 4-BP or (C) 5 µM potassium ferrocyanide for a period of 0 - 420 s. The insets in 
panels A and B show plots of absorbance at 417 nm (A417) as a function of time. The 
inset in panel C follows the A414 and A405 as a function of time to monitor the decay of 
oxy-DHP and rise of ferric DHP, respectively. The gray bold lines on the traces show 
exponential fits for the indicated time ranges, which yield calculated apparent first-order 
rate constants of 4.7 × 10-2 s-1 from A414 and 1.0 × 10-2 s-1 from A405.  
 




























































































stability of this adduct. However, we have been able to detect a DMPO adduct of 4-BP 
(m/z = 285) formed in the DHP-catalyzed H2O2-oxidation of 4-BP in the presence of 
DMPO (Figure 3.10). Significantly, DMPO (10 mM) has no effect on the ferrocyanide-
triggered conversion of oxy- to ferric DHP [kobs: (4.7 ± 0.1) × 10-2 s-1 (Figure 5 C) vs. 
(4.8 ± 0.2) × 10-2 s-1 (Figure 3.2 B)], indicating that the DMPO inhibition on the 
functional switch can be only through trapping the halophenolic radicals.   
DISCUSSION 
        In this study, we have found that not only TCP, but also 4-BP, phenol, ferrocyanide 
and KI can all trigger the H2O2-dependent activation of oxy-DHP [apparent activation 
rates (kobs) listed in Table 3.1]. Since these five compounds have different structures 
(especially the first three phenol derivatives vs. ferrocyanide and KI), yet all are 
peroxidase substrates, i.e., electron donors, it is quite likely that rather than substrate 
(TCP) binding, substrate oxidation is involved in the conversion mechanism. In 
agreement with this supposition, we recently showed that addition of TCP or 4-BP (up to 
2 mM, cf. Km = ~0.3 mM for TCP[36]) does not affect the KO2 values for DHP [3], thus 
ruling out the possibility that TCP triggers the functional switch by binding and 
modulating the O2 affinity [26]. In addition, we have shown clear evidence that blocking 
the catalytic activity of the ferric component in the oxy-DHP sample (using ferric heme 
ligands, Im and cyanide) also blocks the functional switch and such blockage by Im can 
be reversed by HRP (Figure 3.4A) that catalyzes the oxidation of the substrate TCP to its 
radical [4]. Previously, a spin-trapping reagent DIPPMO (5-diisopropoxy-phosphoryl-5-
methyl-1-pyrroline-N-oxide) has been reported to trap the TCP• generated from the 
reaction of ferric or oxy-DHP with H2O2 in the presence of TCP as demonstrated by 31P 
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NMR [26]. However, the identity of the compound formed by the trapping was not 
established and the possible inhibition of the oxy- to ferric DHP or ferryl DHP 
conversion by DIPPMO was not examined in that study. In the present study, we have 
used DMPO as the TCP radical trap to probe the role of TCP in triggering the DHP 
functional switch. The complete inhibition of the TCP/4-BP-triggered (but not the 
ferrocyanide-triggered) activation of oxy-DHP by DMPO confirms the involvement of 
TCP radicals in the DHP functional switch. 
        Based on the results from the present study on the activation of oxy-DHP as well as 
our previous findings [25]. Scheme 3.2 illustrates the mechanism for the H2O2-mediated 
oxidation of oxy-DHP to the ferric state in the presence of substrate TCP (as proposed 
previously [25]) or ferrocyanide (newly found in this study). In the first phase, oxyferrous 
DHP is oxidized to ferric DHP by TCP• or ferricyanide (with bimolecular rate constant 
k1), both of which are the oxidative products gradually generated from the normal 
peroxidase catalytic cycle mediated by the initial trace amount of ferric DHP present in 
the oxy-DHP sample. It is most likely that TCP radical directly oxidizes oxy-DHP as 
previously proposed for lignin peroxidase Cpd III (oxy-peroxidase) [28] while the 
oxidation by ferricyanide occurs via the deoxyferrous form as has been shown for oxy-
Mb [37]. During this phase, TCP• or ferricyanide oxidize oxy-DHP to the ferric state, 
which subsequently forms ferryl DHP upon reacting with H2O2 in the second phase (with 
bimolecular rate constant k2). In the following third/fourth phases, the ferryl DHP species 
(Cpd ES and Cpd II) decay to Cpd II and ferric DHP, respectively, with bimolecular rate 
constants k3 and k4. This is the stage when TCP or ferrocyanide (the product of oxidation 
of oxy-DHP by TCP• or ferricyanide) reduces the ferryl DHP back to ferric state. The  
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Scheme 3.2. Reaction mechanism for H2O2 converting oxy-DHP to ferric state in the 
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values of the bimolecular rate constants k1 (for ferricyanide only), k2 and k4 have been 
determined in this study using stopped-flow technique and are listed in Table 3.2. 
Determination of k3 is not technically feasible because DHP Cpd ES and Cpd II are 
spectrally indistinguishable. Assuming k3 > k4, the rate constants that have been 
determined in this study for Cpd ES + TCP/ferrocyanide reflect the k4 instead of k3 value. 
D’Antonio and Ghiladi have reported the bimolecular rate constant for the reaction of 
ferryl DHP B (prepared from the oxy-form in a similar way as shown in Figure 3.9A) 
with TCP to be 4.1 × 102 M-1 s-1 at pH 8 and 25 oC [26]. This value is on the same order 
of  magnitude as the k value (presumably k4) obtained in this study for DHP A (Cpd ES + 
TCP) at pH 7 and 4 oC (Table 3.2). In the case of HRP, we have shown in a previous 
study that k3 = ~ 3 × 107 M-1 s-1 >> k4 = ~1.5 × 105 M-1 s-1 for ferryl HRP-oxidation of 
TCP at pH 5 [32].        
        As shown in Scheme 3.2, ferric DHP ligands (Im/CN-) effectively inhibit the 
functional switch by blocking the formation of Cpd ES and thus the generation of 
subsequent oxidative products, TCP• or [FeIII(CN)6]3-. DMPO inhibits the functional 
conversion (TCP-triggered only) by trapping the TCP• that oxidizes oxy-DHP to ferric 
state. In the absence of these inhibitors, this reaction cycle continues in an accelerated 
fashion after the initial stage using progressively accumulated ferric DHP and 
regenerated TCP/ferrocyanide.  
        In the proposed mechanism described above, oxy-DHP directly switches to the ferric 
state without formation of any intermediate. However, in the present study on oxy- to 
ferric DHP conversion (with [oxy-DHP] : [H2O2] : [substrate] = 1 : 1 : 1), a ferryl 
intermediate is formed before the appearance of ferric DHP (Figures 3.1 and 3.2B). The 
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apparent inconsistency can be explained using Scheme 3.2. In the beginning of the 
activation reaction, TCP• (or ferricyanide) is gradually generated by the peroxidase 
reaction of H2O2 (initially 1 equiv.) and ferric DHP (initially trace amount). Under such 
conditions, the concentration of TCP• (or ferricyanide) is much less than [H2O2]. 
Consequently, the apparent rate of the initial (oxy- ! ferric DHP) phase (kobs  = k1[TCP•] 
or k1[ferricyanide]) is considerably slower than that of the following (ferric DHP ! Cpd 
ES) phase (kobs = k2[H2O2] = 3.5 × 104  M-1s-1 × 5 µM = 1.8 × 10-1 s-1, Table 3.2). When 
the (oxy-DHP ! ferric DHP) phase becomes progressively faster until it reaches the 
maximum rate [2.3 × 10-2 s-1 (TCP) or 4.8 × 10-2 s-1 (ferrocyanide), Table 3.1], more than 
a half of the initially H2O2 remains since 1 equiv. of oxy- to ferric DHP conversion 
requires 1 equiv. of TCP• generated by consuming only 0.5 equiv. of H2O2. Therefore, 
the (ferric DHP ! Cpd ES) phase (kobs  = k2[H2O2] ≥ 3.5 × 104  M-1s-1 × 0.5 equiv. × 5 µM 
= 8.8 × 10-2 s-1) is still faster than the first (oxy-DHP ! ferric DHP) phase (kobs = 2.3 × 
10-2 s-1, Table 3.1 ).  
        This explains why it is not easy to detect the first phase under the conditions we 
employed in this study. Actually, what we have observed is a combination of two 
sequential phases, i.e. oxy- !ferric ! Cpd ES DHP, with the former phase the rate-
limiting step. As the consumption of H2O2 continues while TCP•/TCP (or 
ferricyanide/ferrocyanide) keeps recycling, the third/fourth phase (ferryl ! ferric DHP, 
kobs = k4[substrate]) become dominant over the second phase (ferric DHP ! Cpd ES, kobs 
= k2[H2O2]) and the ferryl intermediate starts to be reduced back to the ferric state. Thus, 
ferric DHP produced in the first phase is partially converted to ferryl DHP (~45% as 
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shown by the global analysis in Figure 3.1B) and then generated to a ~100% 
stoichiometric amount at the end of the reaction.  
        However, when excess [TCP] is used as in our previous study [25] ([oxy-DHP] : 
[H2O2] : [TCP] = 1 : 1 : 30), the rate of the third/fourth phases (ferryl ! ferric DHP,  kobs 
= k4[TCP] = 9.4 × 102 M-1s-1 × 150 µM = 1.4 × 10-1 s-1) exceeds the apparent ferryl DHP 
formation rate (kobs = 2.3 × 10-2 s-1, Table 3.1). As a result, the ferryl species was not 
detectable and only two species, oxy-DHP and Fe(III) DHP, were observed during the 
activation reaction with a single set of isosbestic points.  
        The first step (oxy- ! ferric DHP) in the activation reaction was not detectable in 
either of the above cases. However, it could be detected when sufficiently high 
concentrations of oxidant (TCP• or ferricyanide) of oxy-DHP are available. In fact, such a 
situation was observed in the reaction of oxy-DHP with equal equiv. of the oxidant 
ferricyanide and H2O2 (Figure 3.3), in which the kobs of the first step slightly exceeds that 
of the second step theoretically (0. 23 vs. 0.18 s-1, calculated from the bimolecular rate 
constants k1 and k2 in Table 3.2 under the conditions employed). We have observed a fast 
phase (0 - 5 s, Figure 3.2B bottom panel) during which ferricyanide first oxidizes oxy-
DHP to the ferric state (0.44 s-1, blue triangles) which subsequently forms ferryl DHP 
upon reacting with H2O2 (0.10 s-1, black circles) in the second phase (5 – 25 s). In the 
following phase (25 - 300 s, Figure 3.2B top panel), ferryl DHP slowly decays (0.008 s-1, 
black circles) along with an increase (absorption decrease) of ferric DHP (0.008 s-1, blue 
triangles). This is a process indicated in Scheme 3.2 as the third/fourth phases when 
ferrocyanide (recycled from oxy-DHP reducing ferricyanide) is reducing ferryl DHP to 
the ferric state.  
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        As already mentioned earlier, a “lag” (slow-phase) time for ~25 s has been found 
before the ferryl DHP formation rate reaches its maximum (right panel inset, Figure 
3.1A). This observation is reasonable if we consider that the conversion reaction starts 
from a trace amount of Fe(III) DHP catalyzing the formation of TCP• and gets 
accelerated until it becomes maximum. On the other hand, direct oxidation of 
deoxyferrous DHP (in equilibrium with the oxy form) by H2O2, as proposed by Ghiladi 
and co-workers, will not explain such a “lag” period, in contrast to the case of the 
reaction of oxy-Mb with H2O2, where no such lag phase is obserbed [38]. Furthermore, 
such direct oxidation of deoxyferrous DHP to the ferryl state by H2O2 would not be 
inhibited by the ferric heme ligands, Im or CN-. Taken together, the ferryl intermediate 
observed in the H2O2-mediated oxy- to ferric DHP conversion is more likely derived 
from H2O2 subsequently reacting with the initially generated ferric DHP, not from H2O2 
directly reacting with ferrous DHP.  
CONCLUSIONS   
        In this report, we have shown that the DHP functional switch from the oxyferrous 
state to the ferric peroxidase active state as a peroxidase, triggered by the co-presence of 
the substrate TCP and H2O2, is inhibited by the ferric heme ligands Im or cyanide as well 
as by the radical trap DMPO.  The present results strongly support our previous proposal 
that the oxyferrous enzyme is directly oxidized to the ferric state by TCP radicals that are 
generated by the peroxidase reaction of ferric DHP (initially present in a trace amount in 
the oxy-DHP sample and progressively accumulating), not simply through a TCP-
induced displacement of bound O2 followed by H2O2 binding. The present report further 
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clarifies how this bifunctional O2 carrier hemoglobin switches to its enzymatically active 
ferric state as a defensive response to the presence of toxic trihalophenol substrates. 
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Supporting Information 
Figure 3.6: Overlaid spectra of oxyferrous DHP/ferric DHP/Cpd ES DHP and simulated 
spectra for mixture of the three using the global analysis data for their time-dependent 
relative popurations in Figure 1B; Figure 3.7: Spectroscopic monitoring of the oxy-DHP 
reacting with 1 eq. H2O2 in the presence of 4-BP or phenol; Figure 3.8: The KCN/Im 
inhibition on the reaction of oxy-DHP with 1 eq. H2O2 in the presence of ferrocyanide; 
Figure 3.9: The DMPO (50 mM) inhibition on the reaction of oxy-DHP with 5 eq. H2O2 
in the presence of TCP; Figure 3.10: Mass spectrum of the 4-BP-DMPO adduct product; 




























































































Figure 3.6. (A) Overlaid normalized spectra of oxyferrous DHP (red), ferric DHP (blue) 
and Cpd ES DHP (green). Cpd ES DHP is obtained from the reaction of 5 µM ferric DHP 
with 50! µM H2O2. Arrows indicate isosbestic points. (B) Simulated time-dependent 
spectra (black lines) of the mixture of the three species (shown in color, which are re-
plotted from panel A) using the normalized relative concentrations (0 – 1.00) at various 





























































































Figure 3.7. Spectral change upon addition of 5 µM H2O2 to 5 !µM oxyferrous DHP in the 
presence of (A) 5 !µM 4-BP or (B) 150 !µM phenol. The insets show the time-dependent 
absorbance changes monitoring disappearance of oxy-DHP [414 nm (A), 417 nm (B)] 
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Figure 3.8. UV-visible spectroscopic monitoring upon addition of 5 µM H2O2 to the 
mixture of 5 µM oxy-DHP and (A) 5 mM KCN or (B) 20 mM Im in the presence of 5 
mM potassium ferrocyanide (0 - 420 s). The insets show the plots of absorbance change 
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Figure 3.9. UV-visible spectroscopic monitoring upon addition of 25 µM H2O2 to the 
mixture of 5 µM oxy-DHP and 5 µM TCP in the (A) absence or (B) presence of 50 mM 
DMPO (0 - 225 s). The insets show the plots of absorbance at 417 nm as a function of 
time for both panels. In panel A inset, apparent first-order rate constant that is calculated 
from an exponential fit (red solid line) is shown. In panel B inset, a straight red line is 







Figure 3.10. Mass spectrum of the 4-BP-DMPO adduct product extracted with ethyl 
acetate after the reaction of ferryl DHP (50 µM) and 4-BP (300 µM) in the presence of 
DMPO (50 mM). Ferryl DHP was generated by adding 300 µM H2O2 to ferric DHP (50 
µM). The structure of DMPO and two candidates for the likely 4-BP-DMPO adduct 



































k1 = 4.6 × 10
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Figure 3.11. Measurements for the bimolecular rate constants k1 and k2 in Table 2. (A) 
Plot of kobs (apparent first-order rate constants) vs. [ferricyanide] for reaction of oxy-DHP 
with ferricyanide. (B) Plot of kobs vs. [H2O2] for reaction of ferric DHP with H2O2. The 
kobs values (solid circles) were calculated from exponential fits for time-dependent 
absorbance changes at 417 nm and 406 nm upon mixing (A) 5 µM oxy-DHP with 5, 10 
and 15 µM potassium ferricyanide and (B) 5 µM ferric DHP with 12.5, 25 and 50 µM 
H2O2 on a stopped-flow spectrophotometer in 0.1 M potassium phosphate buffer, pH 7.0, 
at 4 °C. k1 and k2 were determined by calculating the slopes of the linear correlation as 


















Introduction to Part II: 
















Heme-iron coordination models 
        Heme-iron coordination modeling has been a subject of interest for decades. It 
provides valuable information for identifying newly found heme proteins and better 
understanding their structure-function relationships. Earlier attempts to generate heme 
coordination models has included the total synthesis of the porphyrins with the desired 
ligands attached [1-4]. Although this approach resulted in several good mimics of native 
heme protein active sites, the synthesis is challenging and problematic in yielding 
homogenous complexes.  
        Another method for preparing heme models has been the use of site-directed 
mutagenesis on native heme proteins. Myoglobin (Mb) is a relatively small (~15 kDa) 
and simple heme protein that has been proved to be an ideal scaffold for protein 
engineering. Numerous engineered Mbs have been created with improved native function 
(O2 binding) or artificial enzymatic activities [5-8]. Mb has also been employed for the 
preparation of heme models. Directly replacing the proximal His of Mb by Cys or Tyr 
successfully generates models for P450 and catalase, respectively [9, 10]. However, only 
a quite limited number of models can be prepared by this method due to the structural 
constraints and folding problems found for some mutants. In 1994, Barrick established a 
novel approach to prepare heme models using a H93G Mb cavity mutant. The mutant 
replaces the proximal His93 with a small Gly, leaving a proximal cavity for the binding of 
exogenous ligand to the heme (Figure 4.1). This simple yet creative approach has very 
little limitations in generating desired heme-coordination complexes compared with 





Figure 4.1. A schematic representation for the active site of H93G Mb showing the 








        Our lab has contributed a large array of heme coordination models as mimics of 
native heme proteins with various proximal ligations [11]. For example, the imidazole 
adducts of H93G Mb structurally mimics His-ligated heme proteins such as peroxidases; 
the alkylamine adducts of H93G Mb spectroscopically resemble the Lys-ligated heme 
proteins such as CO oxidation activator (CooA). The H93G Mb adducts can also be 
studied in different iron oxidation states with addition of desired distal probing ligands 
such as CO, NO or O2. All the prepared heme models have been characterized by both 
UV-visible (UV-Vis) absorption and magnetic circular dichoism (MCD) spectroscopy. 
MCD is highly useful as a fingerprinting technique in identifying the heme coordination 
structures because it provides both positive and negative signals (and cross-over points) 
as compared with only the positive features of the UV-Vis absorption spectroscopy. 
Taking advantage of the versatile protein scaffold and the powerful spectroscopic 
technique, we have established a large protein-based heme coordination library that 
contributes valuable knowledge on structure-function relationships of heme proteins. 
 
Cytochrome P450 
        Cytochrome P450 (P450) is a large family of heme-containing monooxygenase 
enzymes that catalyze the insertion of one oxygen atom of O2 to organic substrates (Eq. 
4.1) [12]. The name comes from the unique absorption peak at 450 nm in the ferrous-CO 
state of the enzyme. P450 can be found throughout the biological kingdom with 
important functions such as detoxification of xenobiotics and synthesis of signaling 
molecules (e.g. hormones). 
R3C-H + O2 + 2H+ + 2e- ! R3C-OH +H2O (4.1) 
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        The first solved structure of P450 is that of P450-CAM (CYP 101), a soluble protein 
isolated from a bacteria pseudomonas putida (Figure 4.2) [13]. The protein has a 
molecular mass of ~ 45 kDa consisting of a single polypeptide in an overall triangular 
shape (panel A). The heme cofactor is deeply buried inside with a conserved proximal 
cysteine residue that covalently tethers the heme to the protein backbone (panel B). The 
anionic Cys ligated to the heme iron provide a strong electron push that facilitats O-O 
bond cleavage to form the Cpd I of P450, which is the “active oxygen” intermediate that 
actually oxidizes hydrocarbon substrates [14]. Figure 4.3 schematically illustrates the 
whole catalytic cycle of P450 starting from a H2O-bound six-coordinate low-spin ferric 
resting state (1). Upon substrate binding, the enzyme loses the distal H2O ligand yielding 
a five-coordinated high-spin species (2) which is readily reduced by one electron 
[provided by NADH through an electron-donor iron-sulfur protein putidaredoxin (Pd)] to 
ferrous state (3). The deoxyferrous P450 then bind O2 to form the oxyferrous species (4), 
which is in resonance with a ferric superoxide complex (5). One electron transferred from 
NADH (via Pd) followed by protonation yield the ferric-hydroperoxide (7). The next step 
is the O-O bond heterolysis facilitated by the proximal “thiolate-push” discussed above. 
The resulting active species Cpd I (8) can oxidize inert hydrocarbon substrate camphor 
and return to the resting state. The maintenance of the proximal thiolate ligation to the 
heme iron is crucial for P450 to function.  
 
Models for Cytochrome P450 
        It has been found that proximal heme environment is critical in stabilizing the heme-
thiolate ligation [15]. In Figure 4.4, the proximal Cys357 is in a H-bond network with the  
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(A)                                                                               (B) 
 
Figure 4.2. Front (A) and side (B) views of the structure of P450-CAM from 
pseudomonas putida (pdb accessing code: 2CPP) [13]. Heme prosthetic group is colored 
in green. Panel B shows substrate camphor molecule in red and the proximal cysteine 





Figure 4.3. Reaction cycle for cytochrome P450 showing the core intermediates (adapted 






Figure 4.4 Active site of cytochrome P450-CAM (CYP101) (taken from reference [16]). 
A possible proton delivery network involving a series of hydrogen bonded water 









peptide carbonyl oxygen atoms of  several adjacent residues such as Leu358, Gly359 and 
Gln360. It has been of great interest to build a stable cysteinate-ligated heme structure in 
other heme proteins systems. Early attempts used the approach of site-directed 
mutagenesis. H93C human myoglobin, in which proximial His was replaced by Cys, 
exhibits spectroscopic features that resemble those of ferric P450 as well as significantly 
enhanced peroxidation activity [9]. However, upon reduction, the spectrum of ferrous 
H93C Mb looked quite different from the native ferrous P450, implying the loss of 
proximal thiolate ligation. In another study, the H175C/D235L yeast cytochrome c 
peroxidase (CcP) double mutant was prepared with the proximal His mutated to Cys and 
the nearby Asp replaced by Leu [17]. The purpose of replacing an anionic (i.e. 
carboxylate) Asp235 residue with a nonpolar neutral amino acid Leu in conjunction with 
His175Cys mutation is to help stabilize the negatively charged cysteinate ligation to 
heme iron that favors a hydrogen bond donor rather than hydrogen bond acceptor such as 
Asp. Unfortunately, the MCD spectra of this mutant also only resembled that of P450 in 
the ferric but not the ferrous state. 
        Our lab has been using H93G Mb as a scaffold to prepare models for P450 [18, 19]. 
Titrations of exogenous ligand-free ferric H93G Mb with an extensive series of thiols 
successfully generated mimics for ferric P450 with similar spectroscopic features. 
However, as the previous studies on human Mb and CcP, attempts to reduce the iron to 
ferrous state while retaining the thiolate ligand were unsuccessful. The five-coordinate 
adducts of ferrous H93G Mb with neutral thiol or thioether gave a MCD spectra that were 
similar in general pattern to that of five-coordinate imidazole-ligated ferrous WT Mb but 
quite distinct from that of thiolate-ligated deoxyferrous P450 (Figure 4.3) [18]. This 
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result suggested that the proximal cysteine thiolate might be protonated to yield a neutral 
thiol upon reduction of the heme iron to ferrous state.  
        The difficulty in establishing a stable cysteinate-ligated ferrous heme complex like 
that in ferrous P450 is proposed to be due to weakening of the Fe-S bond that is stable in 
the ferric state (overall charge on the heme iron = 0), but becomes unstable upon 
reduction of the iron (overall charge = -1). Thus, to create a spectroscopic model for 
ferrous P450, an alternative approach would be to use a neutral ligand(s) with donor 
properties similar to the cysteinate thiolate ligand. Alkyl phosphines are neutral ligands 
that have been previously shown to have donor properties similar to thiolates in P450 and 





Figure 4.5 Overlaid MCD (A) and UV-Vis (B) spectra of ferrous H93G(EtSH) complex 
(solid line), deoxyferrous cytochrome P450-CAM (dashed line) and deoxyferrous 
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Mono- and bis-phosphine-ligated H93G myoglobin: Spectral models for 
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To further investigate the properties of phosphines as structural and functional probes of 
heme proteins, mono- and bis-phosphine [tris(hydroxymethyl)phosphine, THMP] adducts 
of H93G myoglobin (Mb) have been prepared by stepwise THMP titrations of exogenous 
ligand-free ferric and ferrous H93G Mb, respectively. Bubbling with CO or stepwise 
titration with imidazole (Im) of the bis-THMP-ligated ferrous protein generated a mixed 
ligand (THMP/CO or THMP/Im, respectively) ferrous complexes. Stable oxyferrous 
H93G(THMP) Mb was formed at -40 °C by bubbling the mono-THMP-Fe(II) protein 
with O2. A THMP-ligated ferryl H93G Mb moiety has been partially formed upon 
addition of H2O2 to the ferric mono-THMP adduct. All the species prepared above have 
been characterized with UV-visible (UV-Vis) absorption and magnetic circular dichroism 
(MCD) spectroscopy in this study. The six-coordinate ferrous bis-phosphine and mono-
phosphine/CO complexes of H93G Mb exhibit characteristic spectral features (red-
shifted Soret/unique-shaped MCD visible bands and hyperporphyrin spectra, 
respectively) that only have been seen for the analogous phosphine or CO-complexes of 
thiolate-ligated heme proteins such as cytochrome P450 (P450) and C. fumago 
chloroperoxidase (CPO). However, such resemblance is not seen in phosphine-ligated 
ferric H93G Mb even though phosphine-bound ferric P450 and CPO display 
hyperporphyrin spectra. In fact, bis-THMP-bound ferric H93G Mb exhibits MCD and 
UV-Vis absorption spectra that are similar to those of bis-amine- and bis-thioether-
ligated H93G Mb complexes. This study also further demonstrates the utility of the H93G 
cavity mutant for preparing novel heme iron coordination structures. 
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INTRODUCTION 
        It is well-known that the functions of heme-containing enzymes largely depend on 
the coordination structures of the iron center [1, 2]. Investigations of the iron oxidation 
and spin state, the amino acids coordinated to the heme iron and the influence of the 
surrounding protein environment provide key information to understand the mechanisms 
of actions of the native heme enzymes [3-5]. To thoroughly study the structures and the 
functions of the diverse heme enzymes, numerous heme iron model systems have been 
developed. Among these approaches, the use of H93G myoglobin (Mb) cavity mutant, 
pioneered by Barrick [6], provides a convenient way to generate heme coordination 
models. The proximal cavity in H93G Mb, formed by replacing the His ligand with a 
smaller non-coordinating Gly, allows exogenous ligands to enter into the active heme 
center of Mb. Our laboratory has successfully prepared several model heme complexes of 
defined structure using H93G Mb, such as H93G Mb imidazole (Im), alkylthiolate and 
carboxylate adducts as mimics of native Mb, cytochrome P450 (P450) and oxyanion-
bound heme proteins, respectively [7-13]. The H93G Mb adducts with a phosphorus-
donor ligand, however, have not been reported yet. Although phosphorus-donor ligands, 
such as phosphines, are not found in native heme proteins, they have been extensively 
used as structural and functional probes of hemoprotein active sites [14-19]. Compared to 
CO, phosphines are more versatile in that they can serve as distal ligands to both ferrous 
and ferric iron of hemoproteins.  
        In particular, we have shown that phosphine-ligated ferric P450 and C. fumago 
chloroperoxidase (CPO), with a thiolate/phosphine ligand set, exhibit the rarely observed 
unusually red-shifted Soret absorption bands that are characteristic of hyperporphyrins 
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[16], previously reported for thiolate-ligated ferric P450 and CPO with a bis-thiolate 
ligand set [20]. This suggested that phosphines have very similar donor properties to 
thiolate ligands and thus that heme adducts with proximal phosphine ligation might be 
spectroscopic mimics of P450.  Further, since phosphines are neutral ligands and it has so 
far not been possible to bind anionic ligands such as thiolates to ferrous or ferryl H93G 
Mb [13] to make H93G models for those P450 states, it seemed plausible that neutral 
phosphines might serve as surrogate thiolates for the generation of ferrous and ferryl 
H93G adducts with spectral properties resembling those of ferrous and ferryl P450.  In 
pursuit of that goal, we have in this study carried out a thorough spectroscopic 
investigation of H93G Mb phosphine complexes in the ferric, ferrous and ferryl states. 
Successful generation of the first H93G Mb spectral models for ferrous P450 and CPO 
will be described. The data reported herein also further expand the already extensive 
H93G Mb heme coordination model library. 
 
MATERIALS AND METHODS 
Materials. 
        Sperm whale H93G Mb was expressed and purified in the presence of 10 mM Im as 
previously described [6, 9]. Im, tris(hydroxymethyl)phosphine (THMP), hydrogen 
peroxide and sodium dithionite were obtained from Sigma/Aldrich. CO and O2 gases 
were purchased from Natural Air Product. 
Sample preparation. 
        Imidazole was removed from the proximal cavity of H93G Mb by means of heme 
extraction and reconstitution with hemin [8]. Concentrations of ferric and ferrous H93G 
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Mb samples were calculated based on ε406 = 112 mM-1 cm-1 in potassium phosphate 
buffer at pH 7.0, 4 °C, which was determined using the pyridine hemochromogen method 
[12, 21]. Complete oxidation of the protein heme iron is accomplished by addition of a 
few crystals of potassium ferricyanide (Fluka) followed by gel-filtration column 
chromatography. THMP and imidazole stock solutions were prepared by dissolving the 
solid in ethanol and water respectively.  
        For the THMP titration experiments, incremental amounts of aliquots from stock 
solutions of 1 mM to 0.5 M THMP in ethanol were added to exogenous ligand-free ferric 
H93G Mb (~25 µM) or ferrous H93G Mb(~3 µM). Comparable amounts of ethanol did 
not produce observable spectral changes. Kd values were determined from hyperbolic 
regression fits of ligand saturation plots. All the titration experiments were conducted at 
pH 7.0 and 4 °C. The complete reduction of ferric H93G Mb to deoxyferrous state was 
achieved by adding solid sodium dithionite to degassed protein solutions. Bubbling CO to 
the bis-THMP-bound ferrous H93G Mb generated the ferrous-CO derivative. For 
imidazole titrations of bis-THMP-bound ferrous H93G Mb that had been prepared by 
dithionite-reduction of the bis-THMP complex of ferric H93G Mb, a 2 M imidazole stock 
solution (pH adjusted to 7.0) was used. The ferrous-O2 complex was generated at -40 °C 
(in a mixed solvent, see below) in a chest freezer by addition of minimal sodium 
dithionite solution to an extensively degassed ferric protein sample containing 0.5 mM 
THMP followed by thorough bubbling with cold O2. The ferryl derivative was generated 




        UV-visible (UV-Vis) absorption spectra were recorded with a Cary 400 
spectrophotometer interfaced to a Dell PC. Magnetic circular dichroism (MCD) spectra 
were measured with a magnetic field strength of 1.41 T by using a JASCO J815 
spectropolarimeter equipped with a JASCO MCD-1B electromagnet and interfaced with 
a Gateway PC through a JASCO IF-815-2 interface unit. Data acquisition and 
manipulation were carried out as previously described [9]. EPR spectra were measured 
with a Bruker EMXplus CW X-band EPR spectrometer using the following conditions: 
microwave frequency, around 9.4000 GHz; microwave power, 0.2 mW (4.5 K) or 10 mW 
(15 K); modulation amplitude, 5.0 G; and modulation frequency, 100.0 kHz. UV-Vis 
absorption spectra and MCD spectra were obtained in 100 mM potassium phosphate 
buffer (pH = 7.0) at 4 °C or in a cryosolvent of glycerol/0.1 M phosphate (70:30 vol/vol) 
buffer at -40 °C and EPR spectra were obtained in 100 mM bicine {2-[bis(2-
hydroxyethyl)amino]acetic acid} buffer (pH = 7.5) at 4.5 K or 15 K. 
 
RESULTS AND DISCUSSION 
THMP binding to exogenous ligand-free ferric H93G Mb [ferric H93G(-L) Mb]and 
spectroscopic characterization of the resulting complexes. 
        Stepwise additions of THMP to ferric H93G(-L) Mb produced spectral changes in 
the Soret and visible regions with two clear sets of isosbestic points during the titration 
(Fig. 1). This indicates that there are two phases throughout the ligand binding reaction. 
In the first phase (Fig. 1A), adding low concentrations (0 - 0.12 mM) of THMP to the 
exogenous ligand-free ferric H93G Mb led to the formation of the mono-THMP 
coordinated species with THMP binding to the proximal side of the heme and involved a 
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decrease in intensity of the Soret peak and an increase in absorbance around 577 nm. The 
assumption that THMP binds first to the proximal side of the heme in exodenous ligand-
free H93G Mb (H93G(-L) Mb) is based on our previous study on imidazole (Im) binding 
to ferric and ferrous H93G(-L) Mb [12]. The preference for the proximal side for such 
relatively large ligands (Im, THMP) is the result of the influence by steric hindrance by 
the distal His-64. With further addition of THMP, a bis-THMP ferric H93G Mb with a 
second THMP binding to the distal side of the heme was gradually formed in the second 
phase.  The Soret abosorption band is red-shifted from 406 nm to 415 nm. New UV-Vis 
spectral features appear in the visible region that are typical of low-spin ferric heme 
complexes consisting of two peaks around ~540 and ~560 nm that develop 
accompanying the appearance of a second set of isosbestic points (Fig. 1B).  
        The titration data were analyzed using a simple biomolecular association scheme 
and the plots of absorbance change vs. ligand concentration were analyzed by a 
regression fit of a saturation plot (difference absorbance change vs. THMP concentration) 
to a hyperbolic curve (Fig. 5.11, insets). The dissociation constant (Kd1) for THMP 
binding to ferric H93G(-L) Mb is ~0.11mM and the Kd2 for THMP binding to mono-
THMP-bound H93G Mb is 5.0 mM (Fig. 5.1, A and B insets, respectively). The THMP 
saturation is not reached with ~10.6 mM ligand added for the second THMP binding due 
to the insufficient phosphine concentration added (saturation: ~ 10.6 / (10.6 + 5.0) = 
~0.68). Higher concentrations of the phosphine were not used because of the slow 
autoreduction of the protein as evidenced by a gradual appearance of an absorption peak 
at ~450 nm (Fig. 1B).  Note that it was a purpose of this study to obtain Kd values to 
confirm formation of homogeneous (i.e., ligand-saturated) complexes, but not necessarily  
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Figure 5.1. UV-Vis absorption spectral changes upon titration of ferric 
H93G(-L) Mb (25 µM in a 0.2-cm cuvette) with THMP in 0.1 M potassium 
phosphate buffer, pH =7.0, at 4 °C. (a) Spectral change in the first phase on 
addition of 0.027, 0.053, 0,11, 0.24, 0.50, 1.02 mM THMP. The dotted line 
represents the last spectra in the second phase on addition of 10.61 mM 
THMP as shown in figure (b). (b) Spectra change in the second phase on 
addition of 1.02, 1.67, 2.97, 5.54, 10.61 mM THMP. The dash-dotted line 
represents the starting spectra of exogenous ferric H93G(-L) Mb and the 
dotted line represents the last spectra in the first phase as shown in figure (a). 
The vertical arrows indicate the directions of absorbance changes. 
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to obtain the values with statistic uncertainties. Nevertheless, reproducibility of the values 
was estimated to be within +/- 10%.  
        Fig. 5.2 displays the UV-Vis absorption and MCD spectra of ferric H93G(-L) Mb 
(dotted line) and ferric H93G(mono-THMP) Mb (solid line) at pH 7.0. Their overall 
MCD band patterns are quite similar. For further comparison, previously published 
spectra of mono-Im (dot-dashed line) and mono-THT (tetrahydrothiophene) complexes 
(dashed line) of ferric H93G Mb [9, 22] are also overlaid in Fig. 5.2. As assigned 
previously, ferric H93G(-L) Mb at pH 7 is a mixture of six-coordinated bis-water-bound 
species and five-coordinate hydroxide adduct with the latter species being predominant at 
pH 7.0 and exhibits a UV-Vis absorption spectrum with a Soret peak at 406 nm and a 
charge transfer band at about 600 nm [22, 23]. Although the Soret region (350 - 450 nm) 
MCD and UV-Vis spectral features of all these heme species are similar to each other, 
their spectral line shapes in the visible region (450 - 670 nm) can be classified into two 
patterns. The high spin charge-transfer visible absorption band at ~605 nm of the ferric 
H93G(-L) Mb shifted to blue (shorter wavelength) upon ligation of THMP and THT, 
while the Im complex shows a distinctly red-shifted band at ~630 nm. The corresponding 
MCD band (trough) intensities and patterns for the two groups are also clearly 
distinguishable. The red-shifted weak MCD trough (~635 nm) and mostly negative 
feature (560 - 670 nm) for the Im adduct are characteristic of a six-coordinate nitrogen-
donor-Fe(III) heme-OH2 coordination mode.  In contrast, more intense MCD features that 
are both negative (troughs) and positive (peaks) in this region appear to be attributable to 
a five-coordinate high spin heme as described above for H93G(-L) Mb and established 
for mono-thioether-ligated heme (based on resonance Raman evidence [24]). Thus, the  
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Figure 5.2. (Top) MCD and (bottom) UV-Vis absorption spectra of ferric 
H93G(THMP) Mb (solid line, 1.03 mM THMP) overlaid with the spectra of ferric 
exogenous ferric H93G(THT) Mb (dashed line, 21 mM THT), ferric H93G(Im) Mb 
(dash-dotted line, 1 mM Im) and ferric exogenous ligand free H93G Mb (dotted line) in 
0.1 M potassium phosphate buffer, pH 7.0, at 4°C. The latter three spectra are replotted 




Figure 5.3. (Top) MCD and (bottom) UV-Vis absorption spectra of ferric H93G(bis-
THMP) Mb (solid line, 17.6 mM THMP), ferric H93G(bis-Im) Mb (dashed line) in 0.1 
M potassium phosphate buffer, pH 7.0, at 4 °C and ferric H93G (bis-THT) Mb (dotted 
line) in 0.1 M potassium phosphate, pH 5.0. The spectra for ferric H93G(bis-Im) Mb 
and ferric H93G (bis-THT) Mb are replotted from Refs. [12] and [22], respectively.  
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mono-THMP adduct of H93G Mb is likely to be also five-coordinate (vide infra, the EPR 
and Conclusions sections). Fig. 5.3 reveals that the UV-Vis and MCD spectra of ferric 
H93G(bis-THMP) Mb adduct that was prepared by addition of 34 mM THMP to ferric 
H93G(-L) Mb at once to minimize autoreduction, have band patterns that are broadly 
similar to those of the previously reported ferric bis-Im H93G Mb as well as the ferric 
bis-thioether (THT) H93G complexes [22] and related bis-Met-ligated heme protein or 
heme-carrier mutants [24, 25]. 
THMP binding to ferrous H93G(-L) Mb and spectroscopic characterization of the 
resulting complexes. 
        Titration of ferrous H93G(-L) Mb with THMP yields mono-THMP-bound ferrous 
H93G Mb with the Kd value of 1.5µM (Fig. 5.12). Comparison of the UV-Vis and MCD 
spectra of this ferrous H93G(THMP) species to those of the previously reported ferrous 
H93G(Im) Mb [12] shows a close similarity except for a small blue shift of ~2 nm in 
Soret region for the THMP complex (Fig. 5.4).  
        Reduction of the ferric bis-THMP H93G Mb with dithionite yielded the 
corresponding ferrous bis-THMP complex. The overall UV-Vis and MCD spectra of this 
adduct (Soret peak at 451 nm and a main band at 546 nm with a shoulder at ~575 nm) 
resemble those of the phosphine adducts of cysteinate-ligated ferrous P450-CAM and 
CPO except for some blue-shifts for the H93G Mb adduct (Fig. 5.5).  In contrast, as 
previously reported, phosphine-bound ferrous Mb has quite different spectroscopic 
features with the Soret peak at 436 and two visible region peaks at 535 and 568 nm ([14], 
this study). This is because Mb has a neutral histidine as its proximal ligand, while in 




Figure 5.4. (Top) MCD and (bottom) UV-Vis absorption spectra of ferrous 
H93G(THMP) Mb (solid line, 250 µM THMP) compared with ferrous H93G(Im) Mb 
(dashed line, 2 mM Im) in 0.1M postassium phosphate buffer, pH 7.0, at 4 °C. The 




Figure 5.5. (Top) MCD and (bottom) UV-Vis absorption spectra of ferrous H93G(bis-
THMP) Mb (solid line, 34 mM mM THMP), bis-(hydroxymethyl)methyl phosphine 
(BHMMP)-bound ferrous P450-CAM (dashed line) in 0.1 M potassium phosphate 
buffer, pH 7.0, at 4 °C and bis- BHMMP-bound ferrous CPO (dotted line) in 0.1 M 
potassium phosphate buffer, pH 6.3. The spectra for phosphine-bound ferrous P450-
CAM and CPO were replotted from Ref. [16]. 
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similarity of theferrous H93G(bis-THMP) complex to the phosphine adducts of ferrous 
P450-CAM as well as CPO is noteworthy. However, the derivative-shaped MCD Soret 
band of ferrous H93G(bis-THMP) Mb is 10 and 6 nm blue-shifted compared to those 
features in the spectra of the corresponding ferrous P450-CAM and CPO phosphine 
complexes, respectively. This is likely due to the differences in the donor properties (bis-
phosphine vs. phosphine/thiolate) of the two axial donor ligands.  
CO, O2 and Im complexes of THMP-ligated ferrous H93G Mb. 
        Treatment of ferrous H93G(bis-THMP) Mb with CO yielded a stable ferrous-CO-
H93G(THMP) Mb adduct that is again spectrally similar to parallel ferrous CO-P450-
CAM and CPO with Soret maximum absorption at 437 nm and a main visible region 
band at 546 nm (Fig. 5.6). In contrast, ferrous-CO Mb exhibits a Soret band at 423 and 
two visible bands at 542 and 579 nm [26].  
        Titrating the bis-THMP-bound ferrous H93G Mb with Im caused the Soret 
absorption peak to shift from 451 nm to 432 nm and the main visible peak at 546 nm to 
split into two peaks at 534 nm and 564 nm (Fig. 5.13). The occurrence of clear single set 
of isosbestic points during the spectra change as well as the good fit of the plot of peak-
to-trough absorbance in the difference spectra (data not shown) vs. Im concentration to 
the regression hyperbolic saturation (Fig. 5.13, inset) indicate a conversion from ferrous 
bis-THMP-bound H93G Mb to a novel THMP/Im mixed ligand-coordinated ferrous 
H93G derivative upon replacement of one of the two THMP ligand with Im. Further 
addition of Im to this THMP/Im mixed ligand complex of ferrous H93G Mb resulted in 
formation of bis-Im-bound adduct whose spectra are identical to those reported 





Figure 5.6. (Top) MCD and (bottom) UV-Vis absorption spectra of ferrous-CO 
H93G(THMP) Mb (solid line, 34 mM THMP), ferrous-CO P450-CAM (dashed line) in 
0.1 M potassium phosphate buffer, pH = 7.0, at 4 °C and ferrous-CO CPO (dotted line) 
in 0.1 M potassium phosphate buffer, pH = 6.0, 4 °C. The spectra of ferrous-CO P450-





Figure 5.7. (Top) MCD and (bottom) UV-Vis absorption spectra of THMP/Im mixed 
ligand-bound H93G Mb (solid line, 50 mM THMP, 400 mM Im), THMP-bound ferrous 
sperm whale Mb (dashed line, 66 mM THMP) and bis-Im-bound ferrous H93G Mb 
(dotted line, 4 M Im) in 0.1M postassium phosphate buffer, pH 7.0. The spectra of the 
bis-Im-bound H93G Mb complex, recorded in this work, are essentially identical to 
those reported previously Ref. [12].  
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mono-THMP/mono-Im mixed ligand complex of ferrous H93G Mb (solid line) with 
those of THMP-bound ferrous sperm whale Mb (dashed line) that was prepared in this 
study. A close match of the spectra, especially in the visible region of the MCD spectra, 
supports the conclusion that both spcecies have the same coordination mode of the heme 
center. 
        Fig. 5.8 illustrates the MCD and UV-Vis spectra of the THMP-ligated oxyferrous 
H93G Mb (solind line) stabilized at -40 °C. Corresponding spectra of THT/O2 complex 
of ferrous H93G Mb (dashed line), oxy-Mb (sperm whale, wild-type) (dotted line) and 
oxy-P450-CAM (dot-dashed line) that have previously been reported from our lab [10, 29] 
are overlaid for comparison. The oxyferrous H93G(THMP) Mb exhibits MCD and UV-
Vis spectral features that are quite similar to those of wild-type oxyferrous Mb in both 
line shape and intensity, but not like those of oxy-P450-CAM, which shows relatively 
weak overall MCD band intensities and a single visible absorption peak (554 nm). 
        These results may be attributed to the difference in the nature of CO and O2 ligands, 
the former of which is a much better pi-acceptor. The differences between these two 
ligands are not prominent for their complexes with the thiolate-ligated heme protein P450 
(or CPO) and both the CO and O2 complexes exhibit a hyperporphyrin spectrum [30,31]. 
On the other hand, their (CO and O2) difference seems to be- come evident when a trans 
ligand is a phosphine in their heme adducts (this study). 
Phosphine-ligated ferryl H93G Mb. 
        Fig. 5.9A demonstrates that incubation of the ferric H93G(mono-THMP) Mb (30 





Figure 5.8. (Top) MCD and (bottom) UV-Vis absorption spectra of oxyferrous 
H93G(THMP) Mb (solid line, 0.5 mM THMP), oxyferrous H93G(THT) Mb (dashed 
line, 5 mM THT, replotted from [10]) at -40 oC, oxyferrous wild-type Mb at -10 oC 
(dotted line; replotted from [29]) and oxyferrous P450-CAM at -30 oC (dash-dotted line; 




Figure 5.9.  (Top) UV-Vis absorption spectra of ferric H93G(THMP) Mb (a) before 
(dashed line) and (b) after (solid line) addition of 36 µM H2O2 (recorded within 3 min 
after H2O2 addition) and (c) the extrapolated ferryl H93G(THMP) Mb spectrum (see 
text) (dash-dotted line) in 0.1M potassium phosphate buffer, pH 7.0, at 4 °C. The H93G 
Mb and THMP concentrations were 30 µM and 1.03 mM, respectively. (Bottom) UV-
Vis absorption spectrum of the extrapolated ferryl THMP-bound H93G Mb (solid line) 
compared to the spectra of ferryl horse heart Mb (dashed line) and extrapolated ferryl 
THT-bound H93G Mb (dotted line). The spectra were recorded in 0.1 M potassium 
phosphate buffer at pH 7.0 at 4 °C. The spectrum of ferryl horse heart Mb was replotted 
from Ref. [32] and ferryl THT-bound H93G Mb from Ref. [22]. 
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406 nm (spectrum a) to 408nm (spectrum b). The intensity of the charge transfer band at 
603 for ferric H93G(THMP) Mb gradually decreases, while two new peaks at 537 and 
578 nm appear. The spectral changes suggest that the ferric state is partially converted to 
a ferryl complex. However, unlike the case of mono-Im-bound ferric H93G Mb (see Fig. 
5.3B, dot-dashed line) ([9] and this work), the 603 nm peak in the UV-Vis spectrum 
(spectrum a) did not completely disappear even after longer incubation time or treatment 
with higher concentration of H2O2. Given the expectation that the ferryl derivative would 
have no peak at 603 nm, it can be estimated that 40% of the ferric starting adduct 
converted to the ferryl derivative. Based on this estimation, the UV-Vis absorption 
spectrum of fully formed ferryl was calculated (Fig. 5.9A spectrum c). The extrapolated 
spectrum thus obtained has a Soret peak at 412 and two visible peaks at 537 and 578 nm. 
Compared to those of ferryl horse heart myoglobin and ferryl H93G(THT) Mb [22], the 
calculated spectrum of the ferryl H93G(THMP) Mb adduct shows quite similar band 
patterns (Fig. 5.9B) confirming that the extrapolation for the ferryl H93G(THMP) 
spectrum is reasonable. The lower intensity of the Soret absorption and the blue shift by 
10 nm are likely due to the distinctions in the donor properties of the proximal axial 
ligands, phosphine vs. imidazole. The MCD spectrum for the ferryl complex of 
H93G(THMP) Mb is not available due to its relatively low stability at 4 °C presumably 
because the phosphine ligand in solution can serve as a reductant of the ferryl H93G Mb 
species. A phosphine-ligated ferryl heme complex has not been previously described.  
EPR characterization of mono- and bis-THMP-ligated ferric H93G Mb.  
        Ferric H93G(-L) Mb exhibits two sets of broad rhombic high spin heme iron EPR 
signals at pH 7.5, 4.5 K [g-values: 6.32, ~5.65 and ~2.0 (1st set) and 6.08, ~5.85 and ~2.0 
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(2nd set)] (Fig. 5.10 a).  This EPR spectral feature at pH 7.5 is similar to that at pH 10.0 
for H93G(-L) Mb as examined in this study [g-values: ~6.56, ~5.42, 2.0 (1st set) and 6.15, 
5.82, 2.0 (2nd set), spectrum not shown]. Similarly two sets of rhombic high spin EPR 
spectrum (6.89, 5.06, 1.92; 6.16, 5.84, ~2) have been observed for ferric heme complex 
of the H20A (His20Ala) mutant of HmuO (bacterial heme oxygenase) at 6 K and pH 10.0, 
where the heme has been shown to have a mono-hydroxide-ligated five-coordinate 
structure [33]. Upon addition of a low concentration (0.2 mM) of THMP to ferric H93G(-
L) Mb at pH 7.5, much sharper and more intense high spin signals appeared (Fig. 5.10, b) 
that apparently consist of two sets of components, one of which is rhombic and has g-
values (6.32, 5.65 and ~2.0) that are very similar to one of the two sets for the phosphine-
free protein (Fig. 5.10, a). The other component showed a relatively small signal at g = 
5.93.  Further addition of THMP (total 10 mM) caused the rhombic signal (g = 6.32, 
5.65) to diminish with the other signal (g = 5.93) intensity slightly increased (Fig. 5.10, 
c).  Although formation of a low spin species is expected when 10 mM THMP is added to 
ferric H93G Mb (see Figs. 1b and 3), low spin EPR signals were only observed when 
temperature was raised to 15 K (Fig. 5.10, d) yielding a set of g-values at 2.97 and 2.26 
(the third, smallest, g-value was not detectable). These values were similar to the 
corresponding low spin g-values of 3.05 and 2.22 of imidazole-bound ferric 
dehaloperoxidase from Amphitrite ornata [34, 35], a His-ligated heme protein, that was 
examined in the same series of experiments in this work.  
        To further analyze the two sets of the high spin signals (Fig. 5.10, b and c), attempts 
were made to deconvolute the overlapping spectra into two-component spectra. 








Figure 5.10. EPR spectra of Fe(III) H93G(-L) Mb (a), + 0.2 mM THMP (b), + 10 mM 
THMP (c and d) at 4.5 K (a – c) and 15 K (d).  Spectra (e) and (f) are isolated 
(deconvolved) rhombic (e) and axial (f) high spin heme components of mono- (e) and 
bis-THMP-bound (f) Protein.  The Y-axis positions for spectra a – f are arbitrarily offset 
for clarity.  The relative signal intensities for b and c are proportional to their actual 
magnitudes, but the intensity for a has been enlarged by 7.5 times.  See text for further 
descriptions. 
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subtracting 70% of spectrum (c) from spectrum (b) to generate spectrum (e) (Fig. 5.10e, 
dashed line). Conversely, the second signal was isolated by subtracting 30% of spectrum 
(b) from spectrum (c) (Fig. 5.10 f, dot-dashed line).  These results demonstrate that the 
first set of signals decreased by a factor of ~3.3 (100/30), i.e., by ~ 70%, while the second 
set increased by ~1.4-fold (100/70) upon the increase in THMP concentration. Thus, the 
two sets of signals seen in spectrum (b) arise from two separate high spin heme species. 
The data also reveal that the g = 5.93 signal belongs to a high spin heme iron with axial 
symmetry (f). The rhombic heme may be assigned to the mono-THMP-bound (five-
coordinate) H93G Mb.  In an analogous case, mono-Met-ligated heme in the ferric 
H229A HtsA (a heme carrier protein) has been shown to contain a five-coordinate heme 
(based on resonance Raman evidence) and to exhibit a rhombic (along with an axial) high 
spin EPR spectrum [24].  Furthermore, the bis-Met-ligated low spin-type heme in 
R98C/H102M cytochrome b562 at pH 4.8 has exhibited a minor but sharp axial high spin 
signal (g = 5.9) together with the main low spin signal (g = 3.16, ~2.25) [25].  The 
authors attributed this signal (g = 5.9) to a probable artifact of freezing. The same 
explanation may be applicable to the present result with bis-THMP-ligated H93G Mb 
(Fig. 5.10, b and c).  In fact the increase in the intensity of the g = 5.93 signal (by ~1.4 
times) is significantly less than expected (~3.3-fold) if it is assigned as a high spin 
component of the bis-THMP adduct formation. Nevertheless, the likelihood that the g = 
5.93 signal originated from the bis-THMP ligated H93G Mb heme cannot be totally 
dismissed. The presence of a small shoulder at ~615 nm in the UV-Vis absorption 
spectrum of this complex at 4 °C may suggest that it is not completely low spin.  In 
summary, in this study we have obtained the rhombic EPR spectra of both high spin 
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mono-THMP-ligated and low spin bis-THMP-ligated ferric H93G Mb.  To our 
knowledge, this represents the first EPR characterization of high and low spin ferric heme 
protein derivatives exclusively ligated by phosphines.  
 
CONCLUSIONS   
        Over the past four decades, numerous heme iron model complexes has been 
prepared and characterized in an effort to develop a better understanding of the 
mechanism of action of native heme-containing enzymes. A large variety of ligands have 
been investigated to generate complexes that mimic the active site of native hemoproteins 
[7-13]. However, phosphines, although used as probe ligands, have never been studied as 
proximal heme iron ligands. Phosphines bind to the distal binding site of heme proteins to 
yield mixed-ligand complexes that display characteristic spectroscopic features [30]. In 
this paper, a novel heme complex with phosphine as a proximal ligand has been 
generated and spectroscopically characterized. The generation and characterization of a 
large set of heme-phosphine complexes substantially expands the spectral database of 
heme coordination structures. 
        As shown in Scheme 1, ferric and ferrous mono- (e and c) and bis-phosphine ligated 
H93G Mb complexes (d and g) have been prepared by THMP titration of exogenous 
ligand-free H93G Mb (a and b). The ferric H93G(THMP) Mb adduct is assigned to be a 
five-coordinate species by analogy to the mono-Met-ligated H229A mutant of the HtsA 
heme carrier protein (whose wild-type counterpart has a His/Met-ligated six-coordinate 
structure heme) [24] as well as mono-THT adduct of H93G Mb [22] footnote 1. The lack of 










Scheme 5.1. Mono- and bis-THMP-ligated ferric and ferrous H93G Mb generated and 
examined in this work. Species d was not isolated but is proposed as an intermediate in 
the formation of e upon binding of mono-THMP to a, where a and e may be in 
equilibrium with e being a predominant species.!
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adducts, in contrast to the mono-Im/H2O six-coordinate complex [6, 9], is most likely due 
to non-optimal (too long) distances between the heme iron and the distal histidine (His-64) 
in the former two H93G Mbs.  Proper distance are required for the distal His to form a 
hydrogen bond to hem iron-ligated water and thus to form a water-bound six-coordinate 
ferric heme complexes (for example, Mb (six-coordinate) vs. HRP (five-coordinate)). 
The ferric bis-THMP adduct exhibits spectral features similar to those of H93G Mb 
ligated with two identical neutral ligands such as bis-Im and bis-THT. The ferrous 
H93G(THMP) Mb has spectra that are nearly identical to those of ferrous H93G(Im) Mb.                           
        Interestingly, the UV-Vis and MCD spectra of six-coordinate ferrous phosphine 
bound H93G Mb show similarities to those of corresponding P450-CAM and CPO 
derivatives: i.e., ferrous H93G(bis-THMP) Mb is spectrally similar to ferrous phosphine-
ligated P450-CAM and corresponding CPO while ferrous CO-H93G(THMP) (h) 
spectrally resembles ferrous CO-P450-CAM and ferrous CO-CPO. To our knowledge, 
this is the first reported non-thiolate-ligated heme model that exhibits spectral features 
comparable to those of thiolate-ligated hemoprotein complexes in the ferrous state. Since 
these unique spectral features were seen Cys/phosphine and Cys/CO complexes [27], but 
not for the Im/THMP (i) and Im (His)/CO adducts (e.g., ferrous-CO H93G(Im) Mb [6, 
9]), such spectral uniqueness of the bis-THMP (g) and THMP/CO (h) derivatives of 
ferrous H93G Mb might be attributed to the difference(s) between these bases, Cys and 
THMP (alkylphosphine)] vs. Im as donor ligands. A most likely factor to explain such 
differences would be the much better nucleophilic (i.e., sigma-donor) nature of Cys 
thiolate and phosphines (phosphorous analog of amines) compared with Im (or amines).   
! 145 
        Furthermore, a phosphine/Im mixed-ligand-bound H93G Mb adduct (i) that has 
been generated and spectroscopically characterized serves as a model of phosphine-
bound sperm whale Mb. Ferryl H93G(THMP) Mb can be partially formed as previously 
reported for ferryl H93G (thioether, THT) Mb and their calculated UV-Vis spectra for 
homogenous ferryl species are quite similar. This is the first detailed study of the H93G 
Mb cavity mutant with phosphine as the axial ligand including the new ferrous-CO and 
ferrous-O2 adducts and the results again demonstrate the capacity of the H93G Mb to 
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Footnote 1: In a previous study on THT binding to ferric H93G(-L) Mb, we speculated that 
the mono-THT-bound protein is a six-coordinate species with THT and hydroxide as 
axial ligands [22].  However, since publication of that paper, we have become aware that 
an analogous mono-Met-ligated heme protein, H229A HtsA, with UV-Vis absorption and 
MCD spectra essentially identical to those of H93G(THT) Mb had been definitively 
characterized as a five-coordinate heme species using resonance Raman spectroscopy 
[24]. Thus, we now believe that the mono-THT-H93G Mb adduct also has a five-
coordinate heme.           
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Figure 5.11. Difference spectra of the THMP titrations of ferric H93G Mb. Insets show 
the hyperbolic regression fit (solid line) of saturation plots (closed circles) for THMP 
binding to (top) exogenous-free ferric H93G Mb and (bottom) mono-THMP-bound 
H93G Mb. Absorbance changes from the peak to trough in difference spectra (ΔΔA437-406 
= ΔA437- ΔA406 , ΔΔA432-424 = ΔA432 - ΔA414) are plotted as a function of total THMP 
concentration. 
Figure 5.12. UV-Vis spectral change on the titration of exogenous ligand free ferrous 
H93G Mb (3 µM in a 1 cm cuvette) with THMP in 0.1 M potassium phosphate buffer, 
pH 7.0, at 4°C. Vertical arrows indicate the directions of absorbance change upon 
addition of 0.78, 1.57, 3.92, 7.84, 15.69, 31.37 µM THMP. Hyperbolic saturation plot 
(solid circle) and its regression fit (solid line) of the titration data is shown in the inset 
where absorbance change at 429 nm is plotted as function of free (= total minus protein-
bound) THMP concentration (0.39, 0.78, 1.73, 5.14, 12.82, 28.45 µM, respectively). 
Figure 5.13. UV-Vis spectra change on the titration of bis-THMP-bound ferrous H93G 
Mb (50 mM THMP) with Im in 0.1 M potassium phosphate buffer, pH 7.0, at 4 °C. 
Vertical arrows indicate the directions of absorbance change upon addition of 2.25, 
11.21, 22.30, 44.10, 86.30, 165.46 mM Im. Hyperbolic saturation plot (solid circle) and 
its regression fit (solid line) of the titration data are shown in the inset, where the peak-to-
trough absorbance change in difference spectra (not shown) (ΔΔA433-454 = ΔA433 - ΔA454 ) 
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